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ABSTRACT 
Major surgery triggers a physiological stress response that results in an 
increase in post-operative metabolic demand and oxygen consumption (V̇O2), 
which must be met by an increased oxygen delivery (DO2). Historical studies 
described the increase in V̇O2 in patients after major surgery and presented 
evidence that the inability to meet this increase oxygen demand and the 
temporal pattern of this oxygen deficit appears to differ according to whether 
patients survive, or develop complications or not. The survival and complication 
profile of patients in modern practice is different from that previously described, 
And the methods employed in these historical studies were invasive and 
inconsistent with contemporary practice. V̇O2 can be measured non-invasively 
with indirect calorimetery, and DO2 calculated from non-invasive cardiac output 
monitors, and haemoglobin and oxygen saturation measurement devices. This 
thesis describes two prospective observational studies which1) validate and 2) 
assess the feasibility of non-invasive measurements of V̇O2 and DO2  and 
explore their temporal patterns after contemporary abdominal surgery. 
These techniques demonstrate moderate to good trending ability when 
measuring changes in V̇O2 and DO2. The non-invasive measurement of V̇O2 
and DO2 is feasible in patients after major abdominal surgery. There appear to 
be distinct patterns of V̇O2 and DO2 after contemporary abdominal surgery in 
those who develop complications or not. Contemporary patterns of net 
cumulative oxygen debt appear to differ from those previously described. 
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Chapter 1 
 
 
INTRODUCTION 
 
 
 
  
 
 
1.1 AIMS OF THIS THESIS 
 
The aim of this thesis was to perform original research to investigate the 
question “what is the oxygen consumption (V̇O2) after contemporary major 
abdominal surgery?” using non-invasive technology and consider if there were 
differences in V̇O2 between patients who developed complications and those 
who did not. 
 
Two research studies were undertaken: 
1) A validation study of the non-invasive measurement of oxygen 
delivery and consumption after elective major abdominal surgery. 
NRES Committee South West - Cornwall & Plymouth: 13/SW/0177 
NIHR CRN 15072 
A prospective observational cohort study was conducted on patients undergoing 
elective major liver resections at the Peninsula Hepato-pancreato-biliary 
Surgical Unit, Derriford Hospital, Plymouth, UK. 
Principal Research Questions: 
a) To determine the validity of non-invasive measurement of V̇O2 using indirect 
calorimetry in a cohort of patients after major abdominal surgery 
b) To determine the validity of non-invasive measurement of DO2 in the same 
cohort using non-invasive measures of cardiac output, oxygen saturation 
and haemoglobin (pulse wave transit time and co-oximetry techniques) 
Secondary Research Questions: 
a) To explore the temporal pattern of postoperative V̇O2 and DO2 by these 
techniques 
 
 
 
2) CO2ST: The Cost in Oxygen of Surgical Trauma – a feasibility study of 
the non-invasive measurement of oxygen delivery and consumption 
after major abdominal surgery 
NRES Committee South West - Cornwall & Plymouth: 14/SW/1109 
ClinicalTrials.gov: NCT02238561 
A prospective observational cohort study was conducted on patients undergoing 
elective major colorectal resections at Derriford Hospital, Plymouth, UK. 
Principal Research Questions: 
a) To determine the feasibility of non-invasive measurement of V̇O2 using 
indirect calorimetry in a cohort of patients undergoing elective major 
abdominal surgery 
b) To determine the feasibility of non-invasive measurement of DO2 in the 
same cohort using non-invasive measures of cardiac output (CO), oxygen 
saturation and haemoglobin concentration (pulse wave transit time and co-
oximetry techniques) 
Secondary Research Questions: 
a) To explore the temporal pattern of post-operative V̇O2 and DO2 measured 
by these techniques, and their relationship with post-operative 
complications as measured by the Post-operative Morbidity Survey (POMS) 
b) Data obtained might allow a formal power calculation for a future study 
examining the relationship between post-operative V̇O2 and adverse 
outcomes 
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1.2 BACKGROUND 
 
Major abdominal surgery can be associated with significant morbidity and 
mortality. It is estimated that worldwide, 234 million people per year have 
surgery requiring an inpatient stay [3]. In the UK, in a study of 4.1 million 
selected non-cardiac surgical procedures, the overall mortality was 1.9%. 
However, concealed within this figure was a subgroup of high-risk patients who 
accounted for 12.5% of inpatient surgical procedures but for >80% of 
postoperative deaths [4, 5]. These patients are older, with complex needs, 
significant comorbidities, and limited physiological reserve [2, 6]. They are 
undergoing major surgery, often performed as an emergency, associated with a 
significant physiological stress response in the peri-operative period [7]. 
Moreover, Khuri et al. [2] reported a series of 105,951 patients whose 
demographic, intraoperative and outcome data were routinely collected in the 
National Surgical Quality Improvement Program (NSQIP) database. They found 
that the most important determinant of decreased postoperative survival was 
the development of at least one of 22 defined complications in the immediate 
postoperative period. Furthermore, the occurrence of a 30-day postoperative 
complication reduced median long-term patient survival by 69% (Figure 1) and 
was more important than pre-operative patient risk and intraoperative factors in 
determining survival after major surgery[2]. In addition, Rhodes et al. [8] found 
that long-term survival after major surgery is related to a number of factors, 
including patient age and avoidance of postoperative complications.  
 
 
 
 
 
 
 
 
 
 
Major postoperative complications have both short- and long-term 
consequences. A recent prospective observational study from Australasia in 
patients aged ≥70 years old undergoing elective non-cardiac surgery showed 
that those suffering at least one major complication had a 30-day mortality rate 
of 14% and significantly increased median total postoperative length of stay 
(LOS) compared to those with uncomplicated recoveries (13 vs. 5 days, 
p<0.001) [9]. The question then arises as to how we predict which patients are 
going to develop complications or not? 
 
Three prominent reports from the Royal College of Surgeons of England, the 
UK National Confidential Enquiry into Patient Outcome & Death (NCEPOD), 
and The European Surgical Outcomes Study (EuSOS) highlighted deficiencies 
in the identification of the high-risk surgical patient and the subsequent planning 
Figure 1 The Effect of Postoperative Complications on Long-term Survival 
Cox survival curves of patients who sustained a 30-day postoperative complication compared with 
those who did not. Reproduced from Khuri et al. (2005) [2] 
 
 
 
of their peri-operative care. They suggested that accurate risk assessment 
would be achieved by objectively measuring functional status and 
cardiopulmonary performance, with proper allocation of critical care resources 
[10-12]. Kehlet and Mythen advocate that pre-operative risk stratification allows 
optimisation of organ dysfunction, advice regarding cessation of alcohol and 
smoking, and also allows assessment and optimisation of cardiopulmonary 
functional impairment [1]. Accurate estimation of risk also helps inform the 
patient of risk/benefit and allows planning of appropriate peri-operative care. It 
would seem that a multi-factorial approach to the management of high-risk 
patients, as advocated in Enhanced Recovery After Surgery (ERAS) protocols, 
focussing on minimising surgical stress and inflammatory responses whilst 
optimising peri-operative care would be the ideal (Figure 2). 
  
 
 
  
Pre-operative 
risk 
assessment 
Optimise organ dysfunction 
Functional assessment 
Prehabilitation             
Cancel surgery           
Minimal surgical intervention 
 
Figure 2 Surgical stress responses & peri-
operative events  
These influence outcome in high-risk surgical 
patients and potential strategies for intervention or 
prevention (* components incorporated into ERAS 
pathways).  
Adapted from Kehlet  & Mythen, 2011 [1] 
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1.3RISK ASSESSMENT OF SURGICAL PATIENTS 
 
Who then, is the high-risk surgical patient? Estimation of the likelihood of 
adverse outcome (mortality and morbidity) after surgery is a central objective of 
pre-operative assessment [5]. A variety of methods have been used to identify 
patients at increased risk of adverse outcome following major surgery and to 
quantity the level of this risk. Risk assessment requires a balance between ease 
of use in the clinical setting and precision in distinguishing between the different 
levels of risk.  
 
Recent UK data indicates that only a minority of high-risk patients are admitted 
directly to critical care after surgery, and that many postoperative deaths occur 
following delayed admission to critical care with initial treatment on a standard 
surgical ward [4, 13]. These results highlight the fact that accurate identification 
of at-risk patients is essential to plan appropriate decision-making about offering 
surgery, aspects of peri-operative care and effective utilisation of expensive 
critical care resources, particularly as the development of early postoperative 
complications is associated with both worse short-term [9] and long-term 
outcomes (Figure 1) [2, 8]. 
 
Shoemaker et al. [14] produced a list of patient characteristics and clinical 
criteria that could be used to define those undergoing “high-risk” surgery. Boyd 
et al. subsequently adapted these, and they are presented in Table 1 [15, 16]. 
Whilst these clearly identify patients at much higher risk than those in the 
general population of patients undergoing surgery, this approach is open to 
subjective interpretation and provides only a dichotomous classification of the 
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presence or absence of risk, rather than a graded or continuous measure of 
risk, and many would argue that they are somewhat out-dated. 
 
Previous severe cardiorespiratory illness  
- Acute myocardial infarction, chronic obstructive pulmonary 
disease, or stroke 
Late-stage vascular disease involving aorta 
Age > 70 years with limited physiological reserve in one or 
more vital organs 
Extensive surgery for carcinoma  
(e.g. oesophagectomy, gastrectomy, cystectomy) 
Acute abdominal catastrophe with haemodynamic instability  
(e.g. peritonitis, perforated viscus, pancreatitis) 
Acute massive blood loss > 8 units 
Septicaemia 
Positive blood culture or septic focus 
Respiratory failure: PaO2 <8.0 kPa on FiO2 >0.4 or mechanical 
ventilation > 48 hours 
Acute renal failure: urea > 20 mmol/l or creatinine > 260 mmol/l 
 
Table 1 Clinical criteria for high-risk surgical patients 
Adapted from Shoemaker et al. (1988) [14]  
 
 
 
Within the pre-operative assessment clinic several approaches to identifying the 
high-risk surgical patient are available.  Many of those currently routinely 
available in such clinics within the UK have limitations to their use: Self-reported 
metabolic equivalent of task (METs), have been shown to correlate poorly with 
other more objective assessments of functional capacity [17]. In addition, a 
study comparing three measures of functional capacity: Duke Activity Status 
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Index (DASI) questionnaire, incremental shuttle walk test, and CPET did find a 
significant correlation existed between the various tests [18]. However, DASI 
and shuttle walks had a poor negative predictive value, with many patients with 
poor questionnaire scores or shuttle walks achieving a satisfactory CPET result, 
which questions their ability to accurately determine risk in a heterogeneous 
surgical population. 
 
Echocardiography is commonly performed pre-operatively to assess cardiac 
function in those perceived to be at high-risk. However, this has limited use 
since it only assesses one element of the oxygen delivery process i.e. cardiac 
function. Indeed, in a retrospective study of 264,824 patients undergoing 
elective non-cardiac surgery in Canada, 15.1% of patients had a pre-operative 
echocardiogram, which was not associated with an improvement in mortality or 
length of stay when compared with matched controls [19]. 
 
Numerous risk scores and risk prediction models are available such as the 
American Society of Anesthesiologists physical status classification (ASA 
score), Lee’s Revised Cardiac Risk Index (RCRI), the Physiological and 
Operative Severity Score for the Enumeration of Mortality and Morbidity 
(POSSUM), and it’s specialty-specific score, ColoRectal POSSUM (CR-
POSSUM), and more recently the Surgical Outcome Risk Tool (SORT) score 
that was developed in conjunction with NCEPOD. These all vary in their ease of 
calculation, but also in their clinical utility and ability to accurately predict 
mortality and morbidity: 
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i. ASA is simple to calculate and has been shown to have a significant 
association with both mortality and post-operative complication, although 
there can be significant interoperator variability, and correct prediction of 
complications can be as low as 16% [20-22]. 
ii. Lee’s RCRI, and the subsequent revisions, were developed to predict 
post-operative cardiac complications, rather than all-cause post-
operative mortality and morbidity, in patients undergoing non-cardiac 
surgery [23]. Studies have shown that the index is predictive of 
cardiovascular mortality [24], however, the NSQIP data demonstrate that 
there is a mortality differential that exists between those with and without 
post-operative complications regardless of type of complication [2]. In 
addition, data from 101 patients undergoing high-risk general surgical 
procedures demonstrate that on day 5 post-operatively, only 4% 
developed cardiovascular complications compared to 19.8% with 
pulmonary complications, 28.7% with infectious complications, 21.8% 
with renal complications and 65.3% with gastrointestinal complications 
[25].  
iii. POSSUM takes into account patient physiological and operative factors 
[26], but is criticised for over-predicting the risk of death by up to six-fold, 
especially for those patients with a predicted risk of mortality <10% [27]. 
CR-POSSUM, is simpler to calculate, but can only be calculated post-
operatively as it requires the degree of peritoneal soiling, complexity of 
surgery and histological staging [28].  
 
Risk prediction scores have an inherent limitation – they can only stratify 
individual patients into groups based on population risk, and cannot accurately 
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allocate risk to the individual. More novel and individualised approaches such 
as plasma biomarkers are gaining in popularity, but their place in peri-operative 
risk stratification remains unclear, and more research is required [29, 30].  
 
Due to the limitations described above, and the importance placed on pre-
operative risk stratification, most would advocate a formal assessment of a 
patient’s capacity to deliver oxygen to metabolically active tissues to identify 
those at “high risk” of morbidity and mortality following surgery, so called 
functional assessment. However, these methods can be resource intensive in 
terms of capital outlay and clinician utilisation. 
 
1.3.1 FUNCTIONAL ASSESSMENT 
 
Prevailing theory is that the premise of assessing functional capacity of patients 
is that major surgery generates a systemic inflammatory response that results in 
an increase in post-operative metabolic demand, which in turn leads to an 
increase in V̇O2 with a consequent increased demand in DO2 [15, 31]. Whilst 
the model is not universally accepted [32], patients with poor cardio-respiratory 
reserve, or pre-existing cardiac or respiratory disease, may struggle to meet this 
metabolic demand and are at increased risk of major cardio-respiratory 
morbidity, or death after surgery [15, 16, 31, 33-36]. 
 
When Bland et al. [37] compared the haemodynamic and oxygen transport 
variables of survivors and non-survivors who were critically-ill following general 
surgical operations, they found that the non-survivors generally had:  
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(a) reduced myocardial performance, with a lower cardiac index (CI) and left 
ventricular stroke work in the presence of high ventricular filling pressures, (b) 
reduced pulmonary function, (c) pulmonary vasoconstriction, and (d) decreased 
DO2 despite maintenance of normal arterial blood gases and comparable 
haemoglobin values [37]. This suggested that the development of an oxygen 
deficit/debt (manifested as tissue hypoxia) was an important determinant in poor 
surgical outcomes [15, 37, 38], and not reflected in traditional measures of heart 
rate, blood pressure and blood gas measurement. Shoemaker estimated 
patients` postoperative oxygen consumption requirement (using their measured 
preoperative baseline V̇O2 corrected for temperature) and suggested that 
oxygen deficit was present when this figure exceeded measured V̇O2. The 
temporal pattern of post-operative oxygen deficit appears to differ according to 
whether patients survive, develop complications or not (Figure 3). 
 
DO2 is dependent on the amount of oxygen in the blood and the cardiac output. 
Shoemaker et al. “optimised” patients considered at high risk (Table 1.) with 
intravenous fluids, inotropes and O2 therapy to so-called “supra-normal values” 
for CO and tissue DO2, demonstrating a reduction in mortality from 28% to 4% 
(p<0.02) [14]. They aimed to test the hypothesis that increased CI and DO2 
were circulatory compensations for increased postoperative metabolism which 
prevented the development of a tissue oxygen debt, and the survivors could 
either attenuate the physiological increase in oxygen demand and/or they could 
increase their DO2 [15]. However, the supra-normal values were derived from 
the median values of survivors of high-risk surgical operations who were 
previously observed to have significantly higher mean CI and DO2, and these 
impressive results favouring targeted DO2 were achieved on a cohort of only 
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4.8% of patients, as only 146/2086 were considered high-risk and a further 45 
patients were excluded as invasive monitoring was not used.   
 
Figure 3 Temporal pattens of post-operative oxygen deficit/excess  
From Shoemaker et al. (1992) [38] 
 
In an RCT Wilson et al. [34] demonstrated that both length of stay and mortality 
rates were improved with pre-operative optimisation of patients with fluids and 
inotropes compared with standard care, based on the hypothesis that these 
improved DO2 [34]. Citing previous work that had shown that if DO2 was less 
than 390 L.min-1.m-2, then tissue oxygenation was inadequate [39], they 
concluded that optimisation of DO2 was beneficial in high-risk surgery. They 
advocated the use of close monitoring as intraoperative blood loss, reductions 
in haemoglobin concentration and CO could cause consequent falls in tissue 
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oxygenation [34]. These interventions would later be called goal directed 
therapy (GDT, section 1.5 page 28 ). 
1.3.2 CARDIOPULMONARY EXERCISE TESTING (CPET) 
 
In addition to the work by Shoemaker and Wilson, a complementary stream of 
research investigated the utility of pre-operative testing of patients` functional 
capacity to increase DO2 (for example cardiopulmonary exercise testing, CPET) 
to predict clinical outcome and thus to triage allocation of resources such as 
post-operative critical care [31]. Risk stratification based on CPET is gaining in 
popularity [40], and usually occurs at dedicated pre-assessment clinics prior to 
admission for surgery and can facilitate shared decision making with the patient, 
the planning of appropriate peri-operative care, and allow pre-operative 
optimisation.  
 
CPET is a comprehensive objective assessment of cardiopulmonary function, 
examining the ability of a patient to meet the oxygen demands seen during 
times of tissue stress such as that seen during and after major surgery. Studies 
have suggested that CPET is able to identify patients with poor functional 
reserve that may be less able to maintain peri-operative DO2, and are therefore 
at risk of morbidity and mortality after surgery [31, 33, 35, 41, 42]. CPET derived 
variables include anaerobic threshold (AT), the point at which aerobic 
metabolism is inadequate to meet the energy demand in exercising muscles, 
thus requiring anaerobic metabolism to make up the deficit; V̇O2 peak, the 
maximum V̇O2 achievable by an individual, and the ventilatory equivalent of 
CO2, calculated as V̇E/V̇CO2, where V̇E = pulmonary ventilation (amount of air 
moved in and out of the lungs per minute), and V̇CO2 = CO2 production. 
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However, in reality the mechanisms defining “fitness” for an individual i.e. their 
resilience to physiological stress, are likely to be complex and multifactorial 
including neurohumoral pathways [43]. 
In a study on 116 patients following major elective general surgery, Snowden et 
al. demonstrated that an AT of 10.1 mlO2/kg/min was able to distinguish 
between those at increased risk of developing post-operative complications with 
a sensitivity of 88% and specificity 79% [35]. Those with >1 complication had a 
significantly longer length of stay (LOS, 26 vs. 10 days; p<0.001) and worse AT 
(9.1 vs. 11.9 mlO2/kg/min; p=0.001). More recently, West et al., in a study of 
703 patients from 6 centres, also showed that  a pre-operative CPET derived 
AT ≤11.1 ml/kg/min, and VO2 peak ≤18.2 ml/kg/min were able to identify 
patients at risk of developing post-operative morbidity [44].  
 
Not only are CPET variables able to predict morbidity, but they are also able to 
predict mortality after surgery. In addition it is the CPET variables that predict 
the outcome rather than the age of patients In a study of 389 patients 
undergoing hepatobiliary surgery, patients were divided into groups according 
to age (</> 75 yrs) and fitness (AT </>10ml/kg/min), with only fitness being the 
independent predictor of mortality and length of stay (Figure 4) [45]. That is to 
say that “fit” older patients, as measured by CPET, do better after major surgery 
than “unfit” younger patients. Moreover, Older et al. [33] demonstrated in 548 
>60 yrs of age undergoing major intra-abdominal surgery it was the AT as 
determined by CPET rather than age that was a discriminator of mortality.  
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Figure 4 Age, fitness, and mortality rates from hepatobiliary surgery in 389 patients  
From Snowden et al. (2013) [45]. (Fit = AT >10ml/kg/min, unfit = AT <10ml/kg/min) 
 
In addition, Wilson et al., in a retrospective analysis of 843 patients who 
underwent major elective colorectal or urological surgery found that V̇E/V̇CO2 
>34, an AT ≤10.9ml/kg/min, and a clinical history of ischaemic heart disease 
were all significant predictors of all cause 30 and 90-day mortality [42]. 
Interestingly the effect of a reduced AT was most pronounced in patients 
without cardiac risk factors, which might suggest some clinical management 
bias with closer monitoring in critical care for those with cardiovascular risk 
factors rather than for those deemed unfit by CPET. Furthermore, in a novel 
study looking at a cohort of patients unable either to perform a CPET test and/or 
demonstrate an AT on CPET, Lai and colleagues  demonstrated that these 
patients had longer LOS and higher early and medium-term mortality than either 
patients stratified as fit (AT ≥11.0ml/kg/min) or unfit (AT <11.oml/kg/min) by 
CPET [46]. 
 
 
 
27 
Work from Torbay Hospital has demonstrated that even just attending a 
specialised pre-operative assessment clinic (during which CPET is performed) 
is independently associated with a 58% lower mortality rate after major 
colorectal surgery [47]. This was thought to be in part explained by more 
frequent planned post-operative admission to the critical care unit. Indeed, in a 
further study of 156 patients undergoing open colorectal surgery from the same 
group [48], patients with an AT ≤11ml/kg/min had fewer cardiac events when 
managed in the critical care unit than when managed on the surgical ward 
(Figure 5.). Carlisle et al. also found that the net income generated by the high-
risk pre-operative clinic (including CPET) reduced the cost of post-operative 
critical care compared to those not seen at the clinic [47].  
 
Table 2 Postoperative cardiac events.  
From Swart & Carlisle (2012) [48] CCU, Critical Care Unit 
1.4 STRESS RESPONSE TO SURGERY 
The stress response to surgery refers to a series of interlinked physiological 
changes that occur in response to a surgical (or traumatic) insult. These include 
a cascade of endocrine, metabolic and immunological responses that evolved 
to improve the chances of survival following injury, however, in modern surgical 
and anaesthetic practice aspects of the response may become maladaptive.  
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Cuthbertson classically described the biphasic hypermetabolic response to 
injury [49]: The initial “ebb” phase begins soon after the injurious stimulus and 
typically lasts 2-3 days and is characterised by a reduction in metabolic activity. 
The subsequent “flow” phase, lasting from days to weeks depending on the 
severity of the traumatic insult, is characterised by a catabolic and hyper-
metabolic response. In reality the two phases are less clearly defined and the 
biphasic concept may not adequately describe the metabolic responses induced 
following surgical insults, however, the correlations established between injury 
and hypermetabolism and the modulation of the physiological responses 
continue to guide advancements in surgical care. 
As a direct consequence of local tissue injury, somatic and visceral afferent 
neuronal signals are transmitted via the ascending spinal pathways to the 
central nervous system. These activate both the sympathetic nervous system 
and the hypothalamic pathways characterised by the increased secretion of 
pituitary hormones [7]. The changes in pituitary secretion have secondary 
effects on hormonal secretion from various target organs, principally the 
adrenals, kidneys, liver and pancreas. Figure 5 summarises the systemic 
responses to surgery. The overall metabolic effect is increased catabolism and 
subsequent substrate mobilisation of carbohydrate (secondary to raised 
glucagon secretion, decreased insulin together with peripheral insulin 
resistance), fat (in response to cortisol and growth hormone) and protein 
(cortisol), and salt and water retention (due to up-regulation of the renin-
angiotensin-aldosterone axis in combination with the effect of antidiuretic 
hormone on the kidney). 
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Figure 5. The systemic responses to surgery 
taken from Moor et al. (2017) [50] 
 
Tissue damage also leads to the local release of chemical mediators by 
activated macrophages, fibroblasts and endothelial cells, principally the 
cytokines, which have both pro- and anti-inflammatory effects. Pro-inflammatory 
cytokines include interleukin (IL)-1, IL-6 and tumour necrosis factor-α (TNF-α), 
which activate acute-phase response protein production from the liver e.g. C-
reactive protein (CRP) and complement factors, which are inflammatory 
mediators, anti-proteinases and in tissue repair. Anti-inflammatory cytokines 
include IL-4, IL-10 and transforming growth factor-β (TGF-β). They can reduce 
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the severity and duration of any systemic inflammatory response, but if 
unregulated can predispose to immunodeficiency and sepsis [51]  
In general, the magnitude and duration of the stress response are proportional 
to the surgical injury and the development of complications.  An unregulated 
response, can lead to the systemic inflammatory response syndrome (SIRS) 
and ultimately multi-organ failure and death. Conversely, modulation of the 
stress response by various interventions is the central tenet of enhanced 
recovery after surgery (ERAS) programmes (Section 1.5, Enhanced recovery 
after surgery, p28), which seeks to diminish the stress response and promote a 
faster recovery time with improved morbidity and short and long term mortality 
[52]. In particular neuroaxial blockade by local anaesthetic agents in epidural or 
spinal anaesthesia prevents afferent activation of the hypothalamus and 
efferent stimulation of the adrenals, liver and pancreas, thus attenuating the 
stress response [7]. Regional anaesthesia has no effect on cytokine levels as 
this is mediated and initiated locally by direct tissue damage. However, this 
effect can be decreased by reducing the duration and magnitude of the surgical 
intervention e.g. with laparoscopic surgery [52]. 
The concept of the stress response to surgery and our understanding of it 
continue to evolve. What remains clear is that it remains a complex multisystem 
phenomenon involving the endocrine, immune and metabolic systems.  
1.5 ENHANCED RECOVERY AFTER SURGERY  
 
Enhanced recovery after surgery (ERAS) pathways, since their inception in the 
1990s by Henrik Kehlet [53], have gained widespread acceptance as the 
standard of care for patients having major surgery. Much of the evidence for the 
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practice has come from colorectal surgery, but the ERAS Society has published 
guidelines for multiple specialties (Table 3).The concept behind ERAS is to 
attenuate the stress response to surgery and improve recovery. It accomplishes 
this via a multimodal approach to the perioperative care of the surgical patient 
(Figure 6), which requires input from multiple members of the multidisciplinary 
team. The key principles are pre-operative counselling, pre-operative nutrition, 
avoidance of perioperative fasting, carbohydrate loading up to 2 hours pre-
operatively, standardised anaesthesic and analgesic protocols, and early 
mobilisation. When applied to colorectal surgery, ERAS pathways have been 
shown to reduce LOS, complication rates and 30-day mortality [54, 55]. 
However, in a meta-analysis of 38 trials covering GI, GU, orthopaedic, thoracic 
and vascular surgery, with a total of 5099 patients, ERAS pathways were only 
shown to reduce LOS (standardised mean difference -1.14 (-1.45 to -0.85)) and 
reduce the risk of all complications within 30 days (RR 0.71 (0.60 to 0.86)), with 
no reduction in mortality (RR 0.69 (0.34 to 1.39)), major complications (RR 0.95 
(0.69 to 1.31)) or readmission rates (RR 0.96 (0.59 to 1.58)) [56]. No individual 
components of the ERAS pathway were identified as independently improving 
outcomes, which suggests that the multi-modal approach of ERAS is akin to 
British Cycling’s Dave Brailsford’s concept of “marginal gains”: 
“The whole principle came from the idea that if you broke down everything 
you could think of that goes into riding a bike, and then improved it by 1%, 
you will get a significant increase when you put them all together” [57]. 
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Table  3 ERAS Society Guidelines by specialty and year of publication 
From Ljungqvist et al. (2017) [58]. 
 
Compliance to ERAS protocols also seems to be important. In a study on 953 
consecutive patients with colorectal cancer in Sweden,  >70% adherence to the 
ERAS protocol significantly reduced adverse outcomes in terms of 30-day 
morbidity, LOS, and readmissions compared with low (<50%) ERAS adherence 
[59]. Moreover, long-term survival seems to be improved with increasing 
adherence, with patients with ≥70% adherence to ERAS pathways, the risk of 5-
year cancer-specific death was lowered by 42% (HR 0.58 (0.39 to 0.88)) [60]. 
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Figure 2 Enhanced Recovery After Surgery 
The multimodal approach 
 
ERAS represents a paradigm shift in the delivery of surgical care, with both 
short and long-term benefits for patients. Contrary to the beliefs of early 
detractors who suggested that the impressive early results showing 2-day 
hospital stays after sigmoid resection [61] was due to careful patient selection, 
similarly impressive results have been seen in high-risk patients with complex 
medical co-morbidities undergoing major surgery [62]. Fit patients having 
laparoscopic colonic resections within an established ERAS protocol can even 
be discharged within 23 hours of surgery without adverse events [63]. 
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1.6 GOAL DIRECTED THERAPY (GDT) 
 
There is perhaps no more controversial subject in perioperative medicine than 
that of fluid therapy. What can be said with any certainty is that the literature is 
inconsistent. Any meta-analysis that has been performed has noted the 
heterogeneity of studies in terms of fluid regimes and outcome definitions [64-
69]. Too little fluid and hypovolaemia can develop, resulting in decreased CO 
and thus impaired tissue perfusion, reduced DO2 and increased morbidity [70], 
an important part of which could be explained largely due to hypoperfusion of 
various tissue beds, most importantly for GI surgery, the splanchnic circulation 
[71, 72]. This can be compounded in GI surgery by prolonged peri-operative 
fasting and mechanical bowel preparation [73], although this has in part been 
offset by the introduction of ERAS pathways [53]. Equally, too much fluid can 
lead to tissue oedema, compromised cardiac and pulmonary function, and 
increase the risk of post-operative ileus [65, 74, 75]. Many hope that the well 
designed RELIEF trial [67] will give the definitive answer as to whether a liberal 
(10ml/kg bolus of balanced crystalloid at initiation of surgery followed by 
8ml/kg/hr until the end of surgery, followed by a maintenance infusion of 
1.5ml/kg/hr for 24 hours), or restrictive (≤5ml/kg bolus of balanced crystalloid at 
induction of anaesthesia followed by 5ml/kg/hr until the end of surgery, followed 
by a postoperative infusion rate of 0.8ml/kg/hr until cessation of iv fluids within 
24 hours) fluid regime is optimum for patients undergoing major abdominal 
surgery. 
 
What is clear is that peri-operative fluid management follows what could be 
termed the “Goldilocks principle”: not too much, and not too little, but just right 
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(Figure 7)! In their systematic review of peri-operative fluid therapy Bundgaard-
Nielsen et al. make the point that “a fixed volume regimen is unlikely to both 
prevent hypovolaemia and the risk of hypervolaemia for every patient”, and that 
“rational perioperative fluid management may include a combination of fixed 
crystalloid administration to replace extra-vascular losses and individualized 
goal-directed colloid administration to maintain a maximal cardiac stroke 
volume” [64]. 
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Figure 7 The optimal fluid administration curve  
From Bellamy (2006) [76] & Bundgaard-Nielsen et al. (2009) [64]. Relationship between perioperative 
administered fluid volume and post-operative morbidity and factors influencing shift of the curve (arrow). 
Curve A represents the hypothesized line of risk. Broken line B represents a division between patient 
groups in a ‘restrictive vs. liberal’ study. Broken line C represents a division between patient and groups in 
an ‘optimised vs. non-optimised’ study. Boxes indicate the risk of complications associated with deviation 
from normovolaemia.  
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As previously discussed, Shoemaker et al. were the first to develop the concept 
of GDT. They described the increase in V̇O2 in patients after major surgery and 
presented evidence that the inability to meet this demand was associated with 
severe post-operative complications and mortality [14, 37, 38]: Shoemaker 
estimated patients` postoperative oxygen consumption requirement (using their 
measured preoperative baseline V̇O2 corrected for temperature) and suggested 
that oxygen deficit was present when this figure exceeded measured V̇O2. The 
temporal pattern of post-operative oxygen deficit appears to differ according to 
whether patients survive, develop complications or not (Figure 3). They then 
optimised patients with intravenous fluids, inotropes and O2 therapy to so-called 
“supra-normal values” for CO and tissue DO2, demonstrating a reduction in 
mortality from 28% to 4% (p<0.02) [14]. Further RCTs were performed, and 
meta-analyses carried out, of protocols which included various methods of 
measuring CO, different fluid regimes and either using vasoactive drugs or not. 
These early studies showed strong benefits in terms of a reduction in 
postoperative morbidity and reduced LOS with GDT compared with 
“conventional” fluid therapy [71, 77-80].  
 
As described above with meta-analyses of liberal vs. restrictive perioperative 
fluid therapy, meta-analysis of GDT is hampered by heterogeneity of study 
design [81, 82]. Despite this, in 2011 NICE issued guidance recommending the 
use of individualised GDT through stroke volume optimisation as a standard of 
care during major surgery [83]. However, more recent trials have not 
demonstrated any benefit to GDT [84-86], which questions the recommended 
ubiquity of stroke volume optimisation by NICE. Indeed, two recent trials from 
 
 
38 
our group in the era of routine ERAS pathways in colorectal surgery, suggest 
that GDT in this patient population may actually cause adverse effects [87, 88]. 
The recent meta-analysis of GDT in colorectal surgery by Srinivasa et al. has 
shown that GDT did not influence LOS or complication rate in the context of 
ERAS pathways, or when compared with fluid restriction [89]. Moreover, in the 
context of bowel function, although GDT results in a shortened time to first 
bowel movement, a shortened time to oral intake and reduced post-operative 
nausea and vomiting, this was only seen outside ERAS pathways and 
colorectal surgery [90]. The most recent meta-analysis of intra-operative GDT in 
elective major abdominal surgery concluded that any historical advantage of 
GDT was attenuated by its combination with ERAS pathways, and that GDT 
may only be of use in the intraoperative care of the high-risk patient [91]. 
1.7 THE NEED FOR FURTHER RESEARCH  
 
Since the 1980’s major advances in perioperative care have greatly reduced the 
risk of dying after surgery and complication rates (reflected in shorter length of 
stay). Recent studies of GDT and CPET suggest that the assumptions made 
from 1980’s studies may not hold – most less fit patients survive surgery and go 
home promptly [35] and GDT may not have the impact of previous studies [84, 
87, 88, 92]. There is the strong possibility that modern care does not trigger as 
much of an inflammatory response as that seen in the 1980’s and 90’s and that 
patients do not need to develop the same increases in V̇O2 and DO2. Indeed, in 
a recent study of patients undergoing major vascular surgery using non-invasive 
techniques to determine V̇O2, Royds et al. did not observe any rise in 
postoperative V̇O2 [93]. 
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Earlier studies used invasive techniques to measure and calculate oxygen 
delivery variables - primarily the pulmonary artery catheter (PAC) – in the 
setting of Intensive Care Units. Thus these studies included only those patients 
who were considered to be at sufficiently high risk to justify the insertion of a 
PAC and admission to a high dependency environment (in general those having 
surgery with a likelihood of extensive tissue trauma and fluid shifts, or those 
with co-morbidities severe enough to potentially impair their ability to generate a 
sustained increase in DO2). Consequently the pattern of postoperative V̇O2 and 
DO2 in fitter patients or those having less extensive body cavity surgery is not 
known. In addition, these methods are not easily applicable to modern care, 
which aims to reduce the impact of surgical and anaesthetic interventions on 
return to normal function and has reduced the number of “lines” being inserted.  
 
Our long-term aim is to use indirect calorimetry to measure resting V̇O2 and 
non-invasive technology to measure DO2 after surgery – replicating 
measurements made 20 – 30 years ago, but in a broader group of patients.  
However, a crucial preliminary step is to validate non-invasive measurement of 
oxygen consumption and oxygen delivery against an accepted standard – 
presented in the first study of this thesis.  
 
Oxygen consumption patterns after “modern” abdominal surgery are not known. 
The second study was designed to help assess the feasibility of non-invasive 
measurement techniques of V̇O2 and DO2 in the perioperative setting. 
Ultimately non-invasive techniques might be applicable to determine which 
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patients are developing “oxygen debt” as a trigger to alter clinical care and 
potentially improve outcome. 
41 
 
CHAPTER 2 
 
 
METHODS 
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This chapter describes the methods used during the studies. Sections 2.1 and 
2.2 describe the general principles of the devices used and Sections 2.3 and 
2.4 describe in detail the individual patient journey for the 2 studies and 
detailed descriptions of data collection including flow diagrams. 
2.1 OXYGEN CONSUMPTION 
2.1.1 Non-invasive measurement 
The GEM (GEMNutrition, Daresbury, UK) is an open-circuit flow-through 
indirect calorimeter [94]. The compact bedside unit measures gas exchange 
volumes, respiratory quotient and energy expenditure. It does this by 
alternately measuring O2 and CO2 concentrations of inspired and expired air. 
Flow rate is continually measured to determine the dilution factor. Gas 
collection is via a comfortable transparent perspex hood placed over the 
patient’s head and chest (Figure 8). 
 
GEM is inaccurate above an FiO2 of 30%, and the system is incompatible with 
ventilators. For this study measurements were conducted on spontaneously 
breathing patients at an FiO2 of 21% (room air), however, for pragmatic 
patient safety reasons, if the patient’s SpO2 fell below 92% an FiO2 of 28% 
was employed and the reading repeated. Further de-saturation on 28% 
oxygen mandated abandoning the recordings at that time point. A recent 
study of post-operative V̇O2 in patients undergoing major vascular surgery 
had similar readings taken with a Douglas Bag on room air without adverse 
effects reported [93].  
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Figure 3 The GEM indirect calorimeter gas collection hood. 
(Picture used with consent of subject) 
 
Laboratory performance tests for the GEM using reference gas injections 
show a mean error of 0.3 ± 2.0% for the measurement of V̇O2 and 1.8 ± 1.0% 
for that of VCO2, which compares favourably to those of other commercially 
available indirect calorimeters, and indicate a clinically insignificant mean 
relative error when measuring these variables [94]. Furthermore, when 
compared to the DeltatracTM Metabolic Monitor (Datex-Ohmeda Inc.), 
although GEM reported higher values of resting metabolic rate (RMR), there 
were no significant differences within repeated measures [95] and therefore 
when used to track changes in V̇O2 could be considered a reliable alternative 
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to Deltatrac, which is no longer commercially available, but has been 
considered as the standard reference tool in indirect calorimetry [96]. 
  
According to the manufacturers recommendations, the GEM was calibrated 
after a 30-minute warm-up. Calibrations were also performed when the cart 
had been idle for more than 20 minutes or after 2 hours of continuous use. 
Calibration utilised two pressurized cylinders of reference gas (BOC): high-
purity N2 for the zero and a gas mixture of nominal composition 20% O2, 1% 
CO2, balance N2 for the span. Monthly ethanol burning tests were performed 
as a quality check, and the manufacturer calibrated the mass flow meter 
annually (Appendix 6). Minute-by-minute V̇O2 averages are displayed on a 
monitor and it typically takes a subject between 5 and 10 minutes to 
acclimatise and for the V̇O2 to settle to a baseline (ΔV̇O2 < 5% on 2 
consecutive readings) - personal communication: Dr A Jeffery, Research 
Nurse, EarlyBird Diabetes Study, which used the GEM to measure RMR in 
300 children every 6 months for 12 years between 2000 and 2012 [97]. This 
was followed by a 5-minute recording period. A mean V̇O2 was then 
calculated for the 5-minute recording period. 
  
 
 
45 
2.1.2 Invasive measurement 
The reverse Fick equation was used to calculate V̇O2. 
  V̇O2 = CO x (CaO2 – CvO2), 
  CaO2 = (Hb x SaO2 x 1.34) + (0.023 x PaO2) 
  CvO2 = (Hb x SvO2 x 1.34) + (0.025 x PvO2) 
Where CO = Cardiac Output, CaO2 = Oxygen concentration of arterial blood 
and CvO2 = Oxygen concentration of mixed venous blood, Hb = haemoglobin 
concentration, PaO2 = partial pressure of Oxygen in arterial blood, PvO2 = 
partial pressure of Oxygen in mixed venous blood. 
 
In our institution pulmonary artery catheterisation is rarely performed. 
However, patients undergoing liver resection surgery routinely have arterial 
and central venous catheters inserted which remain in situ for at least 24 
hours post-operatively to guide post-operative management in the critical care 
setting.  
 
Continuous arterial pulse contour analysis (following calibration by 
thermodilution) using the PiCCOplus (Pulsion Medical Systems, Munich, 
Germany) monitor was initially employed to measure cardiac output. 
PiCCOplus has acceptable agreement and bias in the measurement of 
cardiac output compared with intermittent thermodilution via a PAC provided a 
repeat calibration is performed after any major haemodynamic changes [98-
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100]. PiCCOplus requires a specific proprietary arterial catheter to be placed 
with the transducer tip in either the femoral or axillary artery.   
 
In the early stages of the validation study (n=4) the method of estimating the 
CO was changed due to an adverse event and a near miss. (Appendix 5). All 
adverse event reporting, and changes to the study protocol, adhered to NRES 
and ICH GCP guidelines. Subsequently the LiDCOrapid (LiDCO Ltd, London) 
was used as the CO monitor. LiDCOrapid is a proprietary unit that 
interrogates the arterial trace from a standard arterial line (typically in the 
radial artery) and provides an estimated/nominal CO based on the PulseCO 
algorithm [99]. In the original LiDCO monitor nominal CO can be calibrated 
against a known CO e.g. lithium dilution method, to give an actual CO. 
LiDCOrapid uses the validated algorithm without calibration, as a result in this 
study rather than an absolute value for CO, we utilised an uncalibrated 
nominal value. This is the major limitation of the device and should be 
considered when interpreting results, however, LIDCOrapid has the 
advantage of being minimally invasive, with no potential for direct harm to 
patients. LiDCOrapid has been shown to be within acceptable limits of 
agreement with intermittent thermodilution via PAC [99, 101, 102]. CO was 
transcribed directly onto the case report form (CRF) every minute over the 
same 5-minute period as the GEM measured V̇O2 and a mean CO calculated. 
 
Simultaneous arterial and central venous blood samples were drawn at the 
beginning and end of the 5-minute recording period and placed on ice and 
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immediately analysed in order of time drawn at the end of the 5-minute 
recording period. Thus the maximum time for being stored on ice was 10 
minutes.This allowed measurement and calculation of average arterial and 
central venous oxygen saturations, haemoglobin concentrations, PaO2 and 
the partial pressure of central venous O2 (PcvO2). Central venous oxygen 
saturations (ScvO2) have been shown to correlate well with those of mixed 
venous saturations [103], therefore in the absence of mixed venous readings, 
central venous values were substituted in the above equations to calculate 
V̇O
48 
 
2.2 OXYGEN DELIVERY 
2.2.1 Non-invasive measurement 
DO2 is calculated according to the following equation: 
   DO2 = CO x CaO2 
Where CO = Cardiac Output, CaO2 = Oxygen concentration of arterial blood 
 
EsCCO technology (Nihon Kohden, Japan) utilises a proprietary algorithm to 
provide a real-time estimation of CO from pulse wave transit time i.e. the time 
interval between the R wave of the ECG and the arrival of the arterial 
pulsation wave at an oximeter probe placed on the finger. It has been 
validated against intermittent thermodilution via a PAC as a method to 
characterise CO in critically ill patients [104]. After an interval of approximately 
3 minutes, CO and stroke volume, as well as routine haemodynamic 
variables, are continuously displayed on a monitor. No data is available from 
the manufacturers detailing the time delay from measurement of CO to its 
display on the monitor. Readings were transcribed directly onto the CRF  
every minute over the 5-minute recording period and an average CO 
calculated.  
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Figure 9 The esCCO cardiac output monitor 
 
The Pronto-7 pulse co-oximeter (Masimo Corp, Irvine, CA, USA), is a non-
invasive haemoglobin and oxygen saturation spot-check device. It has a 
spectrophotometric sensor that senses multiple wavelengths of light to 
acquire blood constituent data i.e. different haemoglobin species, and 
determines total haemoglobin levels by applying proprietary algorithms based 
on light absorption [105]. It has been shown to have similar accuracy as the 
HemoCue (HemoCue, Sweden) point-of-care device when compared with a 
laboratory haematology analyser in the outpatient setting, with bias ± standard 
deviation of -0.1 ± 1.1 g/dL and  -0.1 ± 1.6 g/dL respectively [106], and 
comparable accuracy in the trauma patients [107]. The Pronto-7 finger probe 
was placed on the opposite side to the arterial line catheter and readings were 
taken at the beginning and end of the 5-minute GEM recording period and a 
mean value calculated.  
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Figure 10 The Pronto-7 pulse co-oximeter 
Non-invasive CaO2 was calculated as follows: 
  CaO2 = (Hb x SaO2 x 1.34) + (0.023 x PaO2)  
The amount of oxygen dissolved in arterial blood (0.023 x PaO2) was 
disregarded in the calculation, as PaO2 could not be determined non-
invasively. In an average adult male with an Hb = 15 g/dL, an SaO2 = 100%, a 
PaO2 = 13.3 kPa, and a CO = 5 l/min, the difference in CaO2 = 0.3 ml/100ml 
(20.1 vs 20.4 ml/100ml), which equates to a difference in DO2 = 15 ml/min 
(1005 vs 1020 ml/min), or a reduction of < 1.5%, which was deemed 
acceptable on pragmatic grounds. 
2.2.2 Invasive measurement 
CO and CaO2 were measured as described in Section 2.1.2 using the 
PiCCOplus, and subsequently the LiDCOrapid, monitor, combined with 
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arterial blood gas analysis drawn from the arterial catheter in situ. Average 
values were calculated for the 5-minute GEM recording period. 
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2.3 VALIDATION STUDY 
2.3.1 STUDY DESIGN 
This was a prospective observational study of paired minimally invasive 
(standard) and non-invasive measurements of V̇O2 and DO2 at 6 time points 
in the first 24 hours postoperatively in a cohort of 20 patients undergoing 
elective major liver resections between October 2013 and July 2014 at the 
Peninsula Hepatopancreatobiliary (HPB) Surgical Unit, Derriford Hospital, 
Plymouth, UK. Ethical approval was obtained from the NRES Committee 
South West - Cornwall & Plymouth (ref: 13/SW/0177). This study was adopted 
by NIHR (UKCRN ID: 15072).  
 
2.3.2 HPB SURGERY CLINIC 
Patients having major surgery for colorectal liver metastases receive this 
diagnosis at a consultant led clinic and have an opportunity to discuss the 
management of their disease, including an operation, with their surgeon.  
 
An appointment is made for a full pre-operative assessment, and often a date 
for surgery is decided. Patients receive an information pack regarding the 
procedure for pre−assessment. Included within this is information regarding 
the tests they may undergo. At the same clinic they are counselled by a 
cancer nurse specialist regarding potential implications of the diagnosis. 
During this discussion the nurse specialist may inform the patient about 
pre−operative risk assessment using cardiopulmonary exercise testing 
(CPET), if deemed necessary. 
 
 
53 
2.3.3 PRE-OPERATIVE ASSESSMENT 
All patients scheduled for elective liver resections undergo a pre-operative 
assessment at a dedicated clinic. For the majority of patients, this includes 
functional assessment with CPET on a stationary bicycle performed by a 
consultant anaesthetist. Anaerobic threshold (AT) was determined by the V-
slope method with correlation by ventilatory equivalents.  
 
On the basis of the result of the CPET and other factors patients were 
categorised as "normal" risk or "high" risk for peri−operative cardiac or 
respiratory complications. They had an opportunity to discuss the results and 
their implications immediately with a consultant anaesthetist. The results 
influenced the scheduled surgery as follows: they suggested an acceptable 
risk for the particular patient; alternatively a less radical operation, or 
non−operative management was chosen. Such decisions were made by the 
patient and surgeon.  
 
Those patients who did not have a CPET i.e. those considered “fit” by their 
consultant surgeon, still attended a nurse-led preoperative assessment clinic. 
 
During the conduct of the pre-operative assessment, patients who met the 
eligibility criteria were informed about the study by an investigator. Those 
patients who expressed an interest were provided with a patient information 
sheet (Appendix 1). A screening number was then issued and this number, 
date, hospital identification number and patient’s initials were entered onto a 
screening database stored on a secured network drive along with an 
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indication of whether they were agreeable for an investigator to telephone 
later to discuss the study. A telephonic discussion then followed at least 24 
hours later. This provided an opportunity to answer any questions and allow 
assent to proceed with the study. 
 
2.3.4 ELIGIBILITY CRITERIA 
Inclusion and exclusion criteria are shown in Table 4.  
Inclusion Criteria  Aged ≥ 18years 
 Elective major liver resection 
 Post-operative admission to 
High Dependency Unit (HDU) 
 Arterial line and central venous 
pressure line in situ 
Exclusion Criteria  Age <18 years 
 Refusal to participate 
 Requirement for post-operative 
ventilation 
 Requirement for inspired O2 
concentrations (FiO2) >28% to 
maintain O2 saturations  ≥92% 
 
Table 4 Eligibility Criteria for Validation Study 
 
Patients were excluded if they required post-operative mechanical ventilation 
or an FiO2 >28% as the GEM metabolic cart is inaccurate above an FiO2 of 
30% and is incompatible with ventilators. An oxygen saturation ≥92% was 
chosen on a pragmatic patient safety basis.  
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2.3.5 CONSENT 
On the day of surgery, an investigator met with the patient to provide an 
opportunity for further discussion. Formal written consent was then obtained 
on NRES-approved forms (Appendix 2) from those patients willing to proceed 
with the study. 
 
2.3.6 PERIOPERATIVE MANAGEMENT 
All interventions were at the discretion of the operating surgeon and/or 
consultant anaesthetist responsible for the patient. During the conduct of the 
study a locally established Enhanced Recovery After Surgery (ERAS) 
pathway was introduced for patients undergoing liver resections (Figure 11), 
which included pre-operative nutritional supplements (Ensure/EnliveTM) and 
carbohydrate drinks (Pre-OpTM; Nutricia, UK), and standardised post-
operative care. 
 
Patients received a volatile-based general anaesthetic with standard 
monitoring as per AAGBI guidelines [108] along with invasive continuous 
monitoring of arterial and central venous pressure and hourly monitoring of 
urine output.  Local guidelines suggest low thoracic intraoperative and 
postoperative epidural analgesia, but other regional techniques were also 
utilised according to anaesthetist discretion. Fluid management, at the 
discretion of the attending anaesthetist, was typically permissive 
hypovolaemia during dissection and resection phases of surgery, then fluid 
resuscitation to euvolaemia using isotonic crystalloid, colloid, blood products 
and inotropes/vasopressors infusion as indicated.   
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During the early phases of the study a specific brachial arterial line for the 
PiCCOplusTM monitoring system was used, however, following an adverse 
event, and a near miss (Appendix 5), the study protocol was changed to 
employ the LiDCOrapid as the CO monitor. All adverse event reporting and 
changes to the study protocol adhered to NRES and ICH GCP guidelines. 
The LiDCOrapid interrogates the arterial trace from a standard arterial line 
and provides an estimated CO based on the PulseCO algorithm [99].
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Figure 11 Local hemi-hepatectomy ERAS pathway.  
Reproduced from www.erasapp.co.uk
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It is standard practice to allow patients to wake at the conclusion of surgery, 
with only those patients having complicated (e.g. intra-operative 
haemorrhage), or prolonged (typically >6 hours) surgery admitted to the 
intensive care facility ventilated; these patients were excluded from the study. 
Patients typically spent between 30 minutes to several hours in the Recovery 
Area in the main theatre complex where haemodynamic observations are 
taken as well as objective measures of postoperative pain scores. Once 
stable, patients were taken to the High Dependency Unit (HDU), which is an 
area within the main ITU complex. Occasionally patients bypassed the 
Recovery Area and were admitted straight to HDU. 
 
Standardised post-operative care was provided by a dedicated HPB surgical 
team and the ITU medical staff according to a locally introduced ERAS 
pathway (Figure 11). 
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2.3.7 STUDY OBSERVATIONS 
Paired minimally invasive and non-invasive measurements of V̇O2 and DO2 
were commenced at 1 hour after admission to the HDU and then at a further 5 
time points in the first 24 hours post-operatively at least 2 hours apart. All 
observations were made with patients lying in bed with a 30o head up tilt. All 
monitors were placed in the immediate bedside environment of the patient.  
1. The GEM metabolic cart was switched on at least 30 minutes prior to 
any recording taking place and calibrated according to the 
manufacturers instructions. 
2. The esCCO finger probe, ECG dots and arm cuff (Figure 9) and the 
Pronto-7 pulse co-oximeter finger probe (Figure 10) were attached to 
the patient on the opposite side to the arterial line. After an interval of 
approximately three to five minutes haemodynamic variables are 
obtained from the esCCO monitor including estimated CO. 
3. A tympanic measurement of body temperature using a Braun 
Thermoscan® PRO 4000 was taken just prior to the GEM hood being 
placed over the head and chest of the patient (Figure 8). 
Measurements were taken with the patient breathing room air (FiO2 = 
21%), however, if the patient’s SpO2 fell below 92%, an FiO2 of 28% 
was employed. Further desaturation on 28% O2 mandated abandoning 
the recordings at that time-point. Minute-by-minute V̇O2 averages are 
displayed on a monitor, and once the subject had acclimatised (which 
typically takes between 5 and 10 minutes) and the V̇O2 settled to a 
baseline (ΔV̇O2 < 5% on 2 consecutive readings), a 5-minute recording 
period ensued and a mean value calculated. 
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4. At the beginning and end of the 5-minute recording period 2ml blood 
samples were drawn from the arterial and CVP lines and placed on ice 
for a maximum of 10 minutes. These were subsequently analysed in 
time order using the ABL800 FLEX benchtop blood gas analyser 
(Radiometer Medical ApS, Denmark) at the end of the recording period 
and values for Hb, PaO2, PcvO2, SaO2 and ScvO2 obtained and 
averaged over the recording period. 
5. Spot Hb measurements were taken with the Pronto-7 pulse co-
oximeter at the beginning and end of the 5-minute recording period and 
an average value calculated. 
6. CO was directly transcribed at 1-minute intervals over the recording 
period from the esCCO monitor and LiDCOrapid monitor, derived from 
the in situ arterial line trace, and an average value for the recording 
period calculated. (Nb. For the first 4 patients in the study PiCCOplus 
was used to measure CO. This required calibration by 3 
transpulmonary thermodilutions with 20ml of cold normal saline. This 
was performed prior to the GEM hood being placed over the head and 
chest of the subject.) 
7. An estimation of any oral calorific intake in the preceding 1-hour was 
recorded. 
8. At each time point paired mean minimally invasive and non-invasive 
V̇O2 and DO2 were calculated from the recorded data. 
Routine post-operative care was provided at the discretion of the surgical and 
HDU/ITU teams until patients were fit for discharge home. Teams were 
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encouraged to adhere to the locally agreed ERAS pathway.A flowchart for 
clinical data collection and each time point is given in Figure 12.
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Time                 30 mins*            5-10 mins*            5-10 mins      1 min  1 min  1 min  1 min   1 min  5 mins 
        |___________|_______________|_____________|_____|_____|_____|_____|_____|_________________| 
        |     set-up        | acclimatisation |               recording period    | 
       tympanic 
       temperature 
GEM  Switch on    Hood on  | T1 T2 T3 T4 T5  stop & 
  calibrate    start recording            remove hood 
LiDCOrapid§ Continuous       | T1 T2 T3 T4 T5 
  monitoring 
esCCO   Attach &     | T1 T2 T3 T4 T5 
    begin monitoring 
Pronto-7   Attach      |Hb1     Hb2 
Central line§         |sample 1     sample 2  Analyse samples 
Arterial line§         |sample 1    sample 2  Analyse samples 
 
Figure 12 Flowchart for the acquisition of clinical data collection for validation study
 
 
63 
2.3.8 STATISTICAL ANALYSIS 
Previous studies of agreement between methods of CO measurement with 
multiple observations per individual have typically required approximately 100 
paired observations [109], i.e. 6 observations performed on each of 17 
participants. We expanded our sample size to allow for dropouts. In common 
with previous studies we used Bland-Altman analysis corrected for repeated 
measures [109] to compare absolute invasive and non-invasive 
measurements. Results are presented as bias (mean difference between 
measurements), precision (standard deviation, SD, of bias) and 95% limits of 
agreement (bias ±1.96 SD) [109, 110]. The percentage error was calculated 
as 2SD of the bias divided by the mean of the invasive measurement. A 
percentage error of <30% is considered acceptable [111]. 
 
Trends of V̇O2, DO2 and CO have more clinical relevance than point 
estimates, and therefore, the trending ability of the non-invasive techniques 
was assessed by analysing Δnon-invasive values and Δinvasive values on 
four-quadrant plots with concordance rates and polar plot analysis [112, 113].  
 
In studies using thermodilution as the reference CO, concordance rates of 90-
95% support good trending ability [112]. Four-quadrant plots are obtained by 
calculating the differences in consecutively obtained values (e.g. change in 
CO) for both the reference and studied technology and plotting them in a 
scatter plot. Figure 13 shows an example 4-quadrant plot. Values on the x-
axis refer to the change in the measured variable of the reference technology, 
and those on the y-axis for the change in the measured variable of the studied 
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technology. Data on the plot will fall within one of 4 quadrants. If there is a 
positive change in the measured variable in both technologies the data point 
will appear in the upper right quadrant. Correspondingly, a decrease in the 
measured variable in both technologies will result in a data point in the lower 
left quadrant i.e. both these quadrants represent concordant measurements of 
the two technologies and are subsequently shaded green in this example. 
Similarly data points in the quadrants coloured red in the example are 
discordant changes. If the changes in both technologies were identical then 
data points would lie on the line of identity (y=x, the light blue diagonal line on 
the example). The concordance rate is the proportion of data points in the 
green quadrants. Very small changes in a measured variable may be due to 
“noise”, and should not be included in any assessment of trending ability 
[112], therefore a central exclusion zone (typically 0.5 L/min, or 10%, for CO 
monitors) is employed. This is represented by the central light shaded box. 
Data points in this area are not included in the data analysis. 
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Figure 13 Example 4-quadrant plot 
Values on the x-axis refer to the change in the measured variable of the reference technology, and 
those on the y-axis for the change in the measured variable of the studied technology. Data on the plot 
will fall within one of 4 quadrants. If there is a positive change in the measured variable in both 
technologies the data point will appear in the upper right quadrant. Correspondingly, a decrease in the 
measured variable in both technologies will result in a data point in the lower left quadrant i.e. both 
these quadrants represent concordant measurements of the two technologies and are subsequently 
shaded green in this example. Similarly data points in the quadrants coloured red in the example are 
discordant changes. If the changes in both technologies were identical then data points would lie on the 
line of identity (y=x, the light blue diagonal line on the example). The concordance rate is the proportion 
of data points in the green quadrants. Very small changes in a measured variable may be due to 
“noise”, and should not be included in any assessment of trending ability [112], therefore a central 
exclusion zone (typically 0.5 L/min, or 10%, for CO monitors) is employed. This is represented by the 
central light shaded box. Data points in this area are not included in the data analysis. 
 
 
The polar plot was developed by Critchley et al. [112] and is methodologically 
derived from the 4-quadrant plot, but unlike concordance rates, polar plot 
analysis assesses agreement not only in direction of change, but also for the 
magnitude of that change. The x-y co-ordinates are converted to polar co-
ordinates where the radial length of the polar vector represents the magnitude 
of the mean change in consecutive paired non-invasive and invasive 
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measurements. The polar angle represents agreement of the magnitudes of 
change between the methods (i.e. the line of identity) and the mean polar 
angle, or angular bias, indicates how well calibrated the test method is with 
the reference method. The radial limits of agreement is the radial sector that 
contains 95% of data points (analogous to the 95% limits of agreement in 
Bland-Altman analysis) and the 30° angular concordance rate is the 
percentage of data points in the ±30° sector. Critchley and colleagues set 
acceptance limits for good trending ability of an angular bias of <±5°, radial 
limits of agreement of <±30°, and a 30° concordance rate of ≥95%. However, 
in the meta-analysis by Peyton and Chong [114], the authors suggest 
percentage limits of agreement should be increased from ±30% to ±45%, as 
there is a suggestion that in fact the precision error of thermodilution as a 
reference method is closer to ±30%. Therefore, radial limits of <±30o and 
<±45o are reported in this study’s results. A example polar plot is given in 
Figure 14. Mean angular bias is represented by the red line and the radial 
limits of agreement are bounded by the light blue lines. Data points in the red 
shaded area lie outside the ±45o angular concordant sector indicating poor 
trending ability. Data points within the green shaded area are within the 30o 
angular concordant sector and represent good trending ability. Data points in 
the yellow shaded area represent moderate trending ability. A central 
exclusion zone similar to that used in 4-quadrant plots is represented by the 
light shaded area. 
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Figure 14 Example polar plot 
Mean angular bias is represented by the red line and the radial limits of agreement are bounded by the 
light blue lines. Data points in the red shaded area lie outside the ±45
o
 angular concordant sector 
indicating poor trending ability. Data points within the green shaded area are within the 30
o
 angular 
concordant sector and represent good trending ability. Data points in the yellow shaded area represent 
moderate trending ability. A central exclusion zone similar to that used in 4-quadrant plots is 
represented by the light shaded area.
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2.4 CO2ST – A feasibility study 
2.4.1 STUDY DESIGN 
This was a prospective observational study of non-invasive measurements of 
V̇O2 and DO2 pre-operatively and at 8 time points in the first 48 hours 
postoperatively in a cohort of 40 patients undergoing elective major colorectal 
surgery (both open and laparoscopic) between December 2014 and March 
2015 at Derriford Hospital, Plymouth, UK. Ethical approval was obtained from 
the NRES Committee South West – Cornwall & Plymouth (ref: 14/SW/1109). It 
was registered on the ClinicalTrials.gov database (Identifier: NCT02238561). 
 
2.4.2 COLORECTAL SURGICAL CLINIC 
Patients having major abdominal surgery at Plymouth Hospitals NHS Trust 
(PHNT) receive this diagnosis at a consultant led clinic and have an opportunity 
to discuss the management of their disease, including an operation, with their 
surgeon.  
 
An appointment is made for a full preoperative assessment, and often a date for 
surgery is decided. Patients receive an information pack regarding the 
procedure for pre−assessment, which may include pre−operative risk 
assessment using CPET, if deemed necessary. 
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2.4.3 PRE-OPERATIVE ASSESSMENT 
By means of the pre−assessment literature patients may have been offered a 
CPET, conducted by a specialist physiologist or anaesthetist during the course 
of the pre−assessment clinic.  
 
On the basis of the result of the CPET result, patients will be categorised as 
“normal” or “high” risk for peri−operative cardiac or respiratory complications. 
They had an opportunity to discuss the results and their implications 
immediately with a consultant anaesthetist. The patient’s surgeon and GP are 
informed by letter. These results may influence the scheduled surgery as 
follows: they may suggest an acceptable risk for the particular patient; 
alternatively a less radical operation, or non−operative management may be 
chosen. Such decisions are made by the patient and surgeon. 
 
Those patients who did not have a CPET i.e. those considered “fit” by their 
consultant surgeon, still attended a nurse-led preoperative assessment clinic. 
 
The above represents the desired standard of care for all patients scheduled for 
major elective colorectal surgery in PHNT. Up until this point the study is not 
relevant. 
 
During the conduct of the discussion of the pre-operative assessment, patients 
who meet the inclusion criteria were informed about the study by an 
investigator. Those patients who expressed an interest were provided with a 
patient information sheet (Appendix 4). A screening number was then issued 
and this number, date, hospital identification number and patient’s initials were 
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entered onto a screening database stored on a secured network drive along 
with an indication of whether they were agreeable for an investigator to 
telephone later to discuss the study. A telephonic discussion then followed at 
least 24 hours later. This provided an opportunity to answer any questions and 
allow assent to proceed with the study. 
 
2.4.4 ELIGIBILITY CRITERIA 
Inclusion and exclusion criteria are shown in Table 5. Patients were excluded if 
they required post-operative mechanical ventilation or an FiO2 >28% as the 
GEM metabolic cart is inaccurate above an FiO2 of 30%, and is incompatible 
with ventilators. An oxygen saturation ≥90% was chosen on a pragmatic patient 
safety basis. In the validation study only one patient desaturated to 90% (i.e. 
<92%), without adverse sequelae therefore the lower value of 90% was chosen. 
 
Inclusion Criteria  Aged ≥ 18years 
 Elective major colorectal 
resection (open or 
laparoscopic) 
Exclusion Criteria  Age <18 years 
 Refusal to participate 
 Requirement for post-operative 
ventilation 
 Requirement for inspired O2 
concentrations (FiO2) >28% to 
maintain O2 saturations  ≥90% 
Table 5 Eligibility Criteria for CO2ST Study 
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2.4.5 CONSENT 
On the day of surgery, an investigator met with the patient to provide an 
opportunity for further discussion. Formal written consent was then obtained on 
NRES-approved forms (Appendix 5) from those patients willing to proceed with 
the study. 
 
2.4.6 PERIOPERATIVE MANAGEMENT 
All interventions were at the discretion of the operating surgeon and/or 
consultant anaesthetist responsible for the patient. Mechanical bowel 
preparation (MBP) was avoided where possible, and those patients receiving 
MBP routinely received an intravenous infusion of 1-2L of isotonic crystalloid 
prior to arrival in the operating theatre. Patients following the ERAS pathway 
were given pre-operative nutritional supplements (Ensure/EnliveTM) and 
carbohydrate drinks (Pre-OpTM; Nutricia, UK) according to local guidelines. 
 
Patients received a volatile-based general anaesthetic with standard monitoring 
as per AAGBI guidelines [108], along with invasive continuous monitoring of 
arterial and central venous pressure in selected patients, and hourly monitoring 
of urine output.  Local guidelines suggest low thoracic intraoperative and 
postoperative epidural analgesia for open procedures, but other regional 
techniques were also utilised according to anaesthetist discretion. Intra-
operative fluid management was typically targeted fluid therapy, to maintain 
euvolaemia, with isotonic crystalloid. Blood products and 
inotropes/vasopressors were utilised as indicated at the discretion of the 
anaesthetist. 
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Standardised postoperative care was provided on a dedicated colorectal 
surgery ward. Daily ward rounds were conducted by surgical registrars or 
consultants. All patients were allowed free fluids and/or light diet on the evening 
of surgery if tolerated. There was no formal protocol for postoperative fluid 
administration, which was based on clinical need and/or assessment. The 
clinical team were encouraged to adhere to the local ERAS guidelines which 
recommended avoidance of excessive intravenous fluid administration 
(particularly 0.9% Normal Saline) and that they should be discontinued at the 
earliest opportunity. Early mobilisation was encouraged, epidurals were 
discontinued at 48-72 hours, and pain managed with oral analgesics at the 
earliest opportunity. Admission to the Critical Care Unit was at the discretion of 
the surgeon or anaesthetist.   
 
2.4.7 STUDY OBSERVATIONS 
All observations were made with patients lying in bed with 30 degrees head up 
tilt. Pre-operative observations were made on the morning of surgery after 
admission to the pre-operative surgical admission unit. Post-operative 
observations were made at 1, 2, 4, 8, 12, 24, and 48 hours after the completion 
of surgery. 
1.  The GEM metabolic cart was switched on at least 30 minutes prior to 
any recording taking place and calibrated according to the manufacturers 
instructions (see above). 
2. The esCCO finger probe, ECG dots and arm cuff (Figure 10) and the 
Pronto-7 pulse co-oximeter finger probe (Figure 11) were attached to the 
patient. After an interval of approximately three to five minutes 
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haemodynamic variables are obtained from the esCCO monitor including 
estimated CO. 
3. A tympanic measurement of body temperature using a Braun 
Thermoscan® PRO4000 was taken just prior to the GEM hood being 
placed over the head and chest of the patient (Figure 8). Measurements 
were taken with the patient breathing room air (FiO2 = 21%), however, if 
the patient’s SpO2 fell below 90%, an FiO2 of 28% was employed. 
Further desaturation on 28% O2 mandated abandoning the recordings at 
that time-point. Minute-by-minute V̇O2 averages are displayed on a 
monitor, and once the subject had acclimatised (which typically takes 
between 5 and 10 minutes) and the V̇O2 settled to a baseline (ΔV̇O2 < 
5% on 2 consecutive readings), a 5-minute recording period ensued and 
a mean value calculated. 
4. Spot Hb measurements were taken with the Pronto-7 pulse co-oximeter 
at the beginning and end of the 5-minute recording period and an 
average value calculated. 
5. CO was directly transcribed at 1-minute intervals over the recording 
period from the esCCO monitor, and an average value for the recording 
period calculated. 
6. An estimation of the oral calorific intake in the preceding 1-hour was 
recorded. 
7. At each time point mean DO2 was calculated.. 
8. On post-operative day 5, a Post-Operative Morbidity Survey (POMS) 
scale was determined (see section 2.4.8 Post-operative Morbidity 
Survey, p74). For patients who had been discharged earlier than this, a 
day 5 POMS score of 0 was assumed. 
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9. Routine post-operative care was provided at the discretion of the surgical 
and HDU/ITU teams until patients were fit for discharge home. 
A flow chart for clinical data collection  is given in Figure 15
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Time                 30 mins*            5-10 mins*            5-10 mins      1 min  1 min  1 min  1 min   1 min  
        |___________|_______________|_____________|_____|_____|_____|_____|_____| 
        |     set-up        | acclimatisation |               recording period    | 
 
GEM  Switch on    Hood on  | T1 T2 T3 T4 T5  stop & 
  calibrate    start recording            remove hood 
esCCO   Attach &     | T1 T2 T3 T4 T5 
    begin monitoring 
Pronto-7   Attach      |Hb1     Hb2 
 
Figure 15 Flowchart for the acquisition of clinical data collection for feasibility study
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2.4.8 POST-OPERATIVE MORBIDITY SURVEY 
To explore the relationship between post-operative V̇O2 and complications in 
patients having contemporary major abdominal surgery, the severity of 
complications need to be graded. The Post-Operative Morbidity Survey (POMS, 
Table 6) is a simple outcome scale and was designed to produce an easy and 
reliable method of prospectively recording short-term morbidity after major 
surgery  - specifically complications likely to keep a patient in hospital [25, 115]. 
The POMS only records complications by its effect on a system of the body 
rather than specify the actual complication. A POMS score performed on Day 5 
is likely to be discriminative between patients who are recovering well, and 
those who are developing complications. POMS is easily performed, has good 
internal validity and is predictive of a prolonged length of stay [25]. POMS is not 
a simple additive scale; however, patients with a POMS score ≥1 are highly 
likely to remain in hospital, whereas those with a score of 0 are likely to be able 
to go home. 
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Morbidity Type Criteria 
Pulmonary 
Has the patient developed a new requirement for supplemental 
oxygen or other respiratory support 
Infectious 
Currently on antibiotics and/or has a temperature >38
o
C in the last 24 
hours 
Renal 
Presence of oliguria (<500 ml/24hr), increased serum creatinine 
(>30% from pre-operative level), or urinary catheter in place for non-
surgical reason. 
Gastrointestinal 
Unable to tolerate enteral diet for any reason, including nausea, 
vomiting or abdominal distension (use of antiemetic) 
Cardiovascular 
Diagnostic tests or therapy within the last 24 hours for any of the 
following: new myocardial infarction or ischaemia, hypotension 
(pharmacological therapy or fluid therapy >200 ml/hr), arrhythmias, 
cardiogenic pulmonary oedema, thrombotic event (requiring 
anticoagulation) 
Neurological New focal neurological deficit, coma or confusion/delirium 
Haematological 
Requirement for any of the following within the last 24 hours: packed 
erythrocytes, platelets, fresh-frozen plasma or cryoprecipitate 
Wound 
Wound dehiscence requiring surgical exploration or drainage of pus 
from the operation wound with or without isolation of organisms 
Pain 
New postoperative pain significant enough to require parenteral 
opioids or regional analgesia 
 
 
Table 6 The Post-Operative Morbidity Survey (POMS)  
Adapted from Grocott et al. (2007) J Clin Epidemiol; 60: 919-928 [25] 
 
2.4.9 STATISTICAL ANALYSIS 
This is a pilot study to investigate the feasibility of performing these 
observations on the target population and a preliminary investigation of V̇O2 and 
DO2 after surgery. Thus many of the analyses are exploratory and in our cohort 
of  patients we did not expect to see statistically significant correlations between 
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our measurements and outcomes. No power calculation was therefore 
performed. 
 
Shoemaker`s methodology was used to estimate oxygen requirement (V̇O2 
‘need’) at each time point [38]. This was estimated from the baseline pre-
operative V̇O2 corrected for the effects of temperature (which assumed 
“metabolic activity increased or decreased 7 percent per degree Fahrenheit” 
and was calculated as follows:  
 
corrected V̇O2 (V̇O2c) = V̇O2 x 10
-0.036667 x (98.6 – T),  
where T is the patient’s temperature in oF [38]).  
 
The estimated V̇O2 deficit, or excess, at each time point was calculated as the 
difference between the measured V̇O2 and the pre-operative baseline V̇O2 
corrected for temperature. The net cumulative O2 balance at each given time-
point was calculated as the area under the curve (AUC) described by the time - 
V̇O2  deficit/excess curve (Figure 16). 
 
Patients were divided into those with or without major post-op morbidity (as 
quantified by Day 5 POMS score) to see whether differences were apparent in 
the overall AUC of V̇O2 and estimated oxygen debt, or at any of 7 specified time 
points postoperatively.  If so, then the mean values & standard deviations of 
values of the groups would be useful to calculate sample size of a potentially 
larger observational study. 
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To determine if there was a difference in V̇O2, DO2, and cumulative O2 balance 
between those patients who developed complications or not, we used a linear 
mixed model for repeated measures over time by group. This type of modelling 
is applicable to a repeated measures study in which there is unbalance in the 
study groups and makes it possible to prevent list-wise deletion due to missing 
data [116-118]. 
 
 
 
Figure 16 Calculation of net cumulative O2 debt/excess.  
Taken from Shoemaker et al. (1992) [38] 
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Chapter 3 
 
 
A VALIDATION STUDY OF THE NON-INVASIVE MEASUREMENT 
OF OXYGEN DELIVERY AND CONSUMPTION AFTER ELECTIVE 
MAJOR ABDOMINAL SURGERY 
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3.1 INTRODUCTION 
A physiological response to trauma has been recognised for many years [49]. 
The hypermetabolism and hypercatabolism that result is well documented [7, 
119], and is ultimately manifested as an increase in V̇O2, which must be met 
by an increased DO2. Whilst this model is not universally accepted [32], 
several investigators have observed differences between the V̇O2 and DO2 
values of survivors, those who develop organ failure and those who die, and 
subsequently advocated the use of “supranormal” values of V̇O2, DO2 and 
cardiac index (CI) as goals in the treatment of high risk surgical patients, or 
those with sepsis [14, 16, 37, 38, 120, 121] – so-called goal directed therapy 
(GDT), achieved by the administration of intravenous fluid therapy and/or 
inotropes. 
 
Since these original studies were conducted there have been major advances 
in perioperative care that have greatly reduced the morbidity and mortality 
after surgery. Most less fit patients survive surgery and go home promptly 
[35], and GDT may not have the impact of previous studies [84, 87, 92]. There 
is the strong possibility that modern care does not trigger as much of an 
inflammatory response as that seen in the 1980’s and 90’s and that patients 
do not need to develop the same alterations in V̇O2 and DO2. In a recent study 
of patients undergoing major vascular surgery using non-invasive techniques 
to determine V̇O2, Royds et al. [93] did not observe any rise in postoperative 
V̇O2. 
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There are several techniques available for the measurement of V̇O2. Directly 
measured V̇O2 with a water-sealed spirometer remains the ‘gold-standard’ 
method [122], but is technically challenging outside of the laboratory setting. 
Indirect calorimetry, derived from the measurement of inspired and expired 
respiratory gases, can be performed either with metabolic gas monitors, or 
using mass spectrometry. However, until recently these methods were rather 
slow and cumbersome [123, 124], which meant that the only practical method 
available to clinicians and researchers was to calculate V̇O2 using the reverse 
Fick method. The Fick equation utilises CO, usually measured by 
thermodilution (with a pulmonary artery catheter, PAC), and arterial and mixed 
venous blood gases to calculate DO2 and V̇O2: 
V̇O2 = CO x (CaO2 – CvO2), 
   CaO2 = (Hb x SaO2 x 1.34) + (0.023 x PaO2) 
   CvO2 = (Hb x SvO2 x 1.34) + (0.025 x PvO2) 
  DO2 = CO x CaO2 
Where CO = Cardiac Output, CaO2 = Oxygen concentration of arterial blood and CvO2 
= Oxygen concentration of mixed venous blood, Hb = haemoglobin concentration, 
PaO2 = partial pressure of Oxygen in arterial blood, PvO2 = partial pressure of Oxygen 
in mixed venous blood. 
Thus studies included only those patients who were considered to be at 
sufficiently high risk to justify the insertion of a PAC and admission to a high 
dependency environment (in general those having surgery with a likelihood of 
extensive tissue trauma and fluid shifts, or those with co-morbidities severe 
enough to potentially impair their ability to generate a sustained increase in 
DO2). Furthermore, in recent years PAC use has significantly reduced [125] 
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with no evidence of benefit to its routine use, and the risk of significant 
adverse events [126, 127]. Consequently the pattern of V̇O2 and DO2 after 
contemporary high-risk surgery, or in fitter patients or those having less 
extensive body cavity surgery, is not known. Our long-term aim is to explore 
the feasibility of using non-invasive techniques to measure V̇O2 and DO2 after 
surgery. This study describes the crucial preliminary step, which is to validate 
these methods in the perioperative setting against an accepted standard.  
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3.2 METHODS 
For more detailed methods please refer to Chapter 2. This single-centre 
prospective observational study was conducted on patients undergoing 
elective major liver resections at the Peninsula Hepato-pancreato-biliary 
Surgical Unit, Derriford Hospital, Plymouth, UK, between October 2013 and 
July 2014. Ethical approval was obtained from the NRES Committee South 
West - Cornwall & Plymouth (ref: 13/SW/0177). This study was adopted by 
NIHR (UKCRN ID: 15072).  
 
All patients scheduled for elective liver resections undergo a pre-operative 
assessment at a dedicated clinic. During the conduct of the pre-operative 
assessment, patients were provided with written information (Appendix 1) and 
invited to consider participation in the study. Written informed consent was 
obtained from all participants (Appendix 2). 
 
All interventions were at the discretion of the operating surgeon and/or 
consultant anaesthetist responsible for the patient. Standardised post-
operative care was provided by a dedicated HPB surgical team and the ITU 
medical staff, according to a locally introduced ERAS pathway. Patients were 
allowed to wake at the conclusion of surgery, with only those patients having 
complicated (e.g. intra-operative haemorrhage), or prolonged (typically >6 
hours) surgery admitted to the intensive care facility ventilated; these patients 
were excluded from the study.   
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Paired minimally invasive and non-invasive measurements of V̇O2 and DO2 
were commenced at 1 hour after admission to the HDU and then at a further 5 
time points in the first 24 hours post-operatively at least 2 hours apart. All 
observations were made with patients lying in bed with a 30o head up tilt. 
Measurements were taken simultaneously therefore there was no requirement 
to correct for temperature.  
Measurement of V̇O2 
Non-invasive measurement 
The GEM (GEMNutrition, Daresbury, UK) is an open-circuit flow-through 
indirect calorimeter. The compact bedside unit measures gas exchange 
volumes, respiratory quotient and energy expenditure. It does this by 
alternately measuring O2 and CO2 concentrations of inspired and expired air. 
Gas collection is via a comfortable transparent perspex hood placed over the 
patient’s head and chest (Figure 9). GEM is inaccurate above an FiO2 of 30%, 
and the system is incompatible with ventilators. For this study measurements 
were conducted on spontaneously breathing patients at an FiO2 of 21% (room 
air). Minute-by-minute V̇O2 averages are displayed on a monitor and it 
typically takes a subject between 5 and 10 minutes to acclimatise and for the 
V̇O2 to settle to a baseline (ΔV̇O2 < 5% on 2 consecutive readings). This was 
followed by a 5-minute recording period. A mean V̇O2 was then calculated for 
the 5-minute recording period. 
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Invasive measurement 
The reverse Fick equation was used to calculate V̇O2. In our institution 
pulmonary artery catheterisation is rarely performed. However, patients 
undergoing liver resection surgery routinely have arterial and central venous 
catheters inserted which remain in situ for at least 24 hours post-operatively to 
guide post-operative management in the critical care setting. CO was 
measured using the LiDCOrapid monitor (LiDCO Ltd, London, UK) and an 
average calculated for the 5-minute GEM recording period. Simultaneous 
arterial and central venous blood samples were drawn at the beginning and 
end of the 5-minute recording period and analysed with the ABL800 FLEX 
benchtop blood gas analyser (Radiometer Medical ApS, Denmark). This 
allowed measurement and calculation of average SaO2, Central venous 
oxygen saturations (ScvO2), Hb concentration, PaO2 and the partial pressure of 
central venous O2 (PcvO2). ScvO2 have been shown to correlate well with 
those of mixed venous saturations [103], therefore in the absence of mixed 
venous readings, central venous values were substituted in the Fick equation 
to calculate V̇O2.  
Measurement of DO2 
DO2 was calculated according to the following equation: 
   DO2 = CO x CaO2 
   CaO2 = (Hb x SaO2 x 1.34)  
The amount of oxygen dissolved in arterial blood (0.023 x PaO2) was 
disregarded in the calculation, as PaO2 could not be determined non-
invasively (see chapter 2.2.1).  
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Non-invasive measurement 
Non-invasive CO was measured using the esCCO (Nihon Kohden, Japan) 
monitor and an average calculated for the 5-minute GEM recording period. 
esCCO provides a real-time estimation of CO from pulse wave transit time i.e. 
the time interval between the R wave of the ECG and the arrival of the arterial 
pulsation wave at an oximeter probe placed on the finger.  
 
Hb and SaO2 were measured with the Pronto-7 pulse co-oximeter (Masimo 
Corp, Irvine, CA, USA) at the beginning and end of the GEM recording period 
and an average calculated. 
Invasive measurement 
CO values were obtained from the LiDCOrapid monitor. Hb concentration and 
SaO2 values obtained from arterial blood gas analysis. Average values were 
calculated for the 5-minute GEM recording period. 
Statistical analysis 
Full details regarding the statistical analysis employed can be found in section 
2.3.8 including an illustrated guide to interpretation for the 4 quadrant and 
polar plots. Brief details of statistical tests are provided here: 
 
Previous studies of agreement between methods of CO measurement with 
multiple observations per individual have typically required approximately 100 
paired observations [109], i.e. 6 observations performed on each of 17 
participants. We expanded our sample size to allow for dropouts. In common 
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with previous studies we used Bland-Altman analysis corrected for repeated 
measures to compare absolute invasive and non-invasive measurements.  
 
Trends of V̇O2, DO2 and CO have more clinical relevance than point 
estimates, and therefore, the trending ability of the non-invasive techniques 
was assessed by analysing Δnon-invasive values and Δinvasive values on 
four-quadrant plots with concordance rates and polar plot analysis [112, 113].  
 
Data was analysed and graphs produced using Microsoft® Excel® for Mac 
2011 and SigmaPlot® version 13.0 (Systat Software Inc., San Jose, California, 
USA).
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3.3 RESULTS 
One hundred and eleven patients were screened during the study period 
between October 2013 and July 2014 (Figure 17). Twenty-seven patients 
were not for surgical intervention and 1 patient declined surgery. Of those who 
underwent pre-operative assessment (n=83), eleven were ineligible as they 
were not scheduled for a post-operative HDU admission, seven patients 
declined participation (six of these were due to claustrophobia), six were not 
recruited due to an investigator not being available, and one patient required a 
translator. 
 
Fifty-eight patients were recruited. Nineteen subsequently did not meet the 
eligibility criteria (no admission to HDU, n=14, post-operative ventilation, n=5), 
six patients withdrew from the study, no investigator was available for three 
patients, and one patient was unable to tolerate the GEM hood due to post-
operative confusion. Four patients had their scheduled date of surgery after 
the completion of the study (i.e. August 2014, or later). Four patients entered 
the study prior to a change in protocol (see Appendix 3) and are not included 
in the current analysis of V̇O2 and DO2. 
 
A total of one hundred and nine paired minimally invasive and non-invasive 
measurements from twenty-one patients were collected for V̇O2, DO2, CO, Hb 
concentrations, and SpO2. Patient characteristics are shown in Table 7.  
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Figure 17 Validation Study population.   
* 6/7 pts who refused suffered from claustrophobia. ** See Appendix 5 
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Table 7 Patient characteristics.  
Data are expressed as mean (SD) or number  
 
Bland-Altman analysis is the conventional method for comparing 
measurement methods. In this study we used repeated measures on each 
subject, therefore this was corrected for in the analysis as previously 
described [109]. Results are presented as bias (mean difference between 
measurements), precision (standard deviation, SD, of bias) and 95% limits of 
agreement (bias ±1.96 SD) [109, 110]. The percentage error was calculated 
as 2SD of the bias divided by the mean of the invasive measurement. The 
tested method is considered interchangeable with the reference method when 
the percentage error is <30% [111]. This assumes a precision of ±20% for the 
reference method. 
 
Bland-Altman plots of V̇O2, DO2, CO, Hb concentrations, and SpO2 are 
presented in Figures 18-24, with bias, standard deviation (precision), 95% 
limits of agreement and percentage error shown in Table 8. 
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Table 8 Statistical data from Bland-Altman analysis, four-quadrant plots and polar plots for VO2, DO2, CO, Hb and O2 saturations when measured non-invasively 
compared to “standard” methods.  
Highlighted data points demonstrate accuracy (mean bias), and trending ability (concordance from 4-quadrant plots, and angular concordance rates from polar plots) or the 
named technologies when compared with the reference devices. 
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Figure 18 Scatter plot and Bland-Altman Plot for VO2 measurements 
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Figure 19 Scatter plot and Bland-Altman Plot for DO2 measurements 
 
 
95 
Figure 4 Scatter plot and Bland-Altman Plot for CO measurements 
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Figure 21 Scatter plot and Bland-Altman Plot for arterial versus Pronto-7 [Hb] 
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Figure 22 Scatter plot and Bland-Altman Plot for central venous versus Pronto-7 [Hb] 
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Figure 23 Scatter plot and Bland-Altman Plot for arterial versus central venous [Hb]
 
 
99 
Figure 24 Scatter plot and Bland-Altman Plot for SaO2 versus Pronto-7 SpO2 
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Trends of V̇O2, DO2 and CO have more clinical relevance than point 
estimates, and therefore, the trending ability of the non-invasive techniques 
was assessed by analysing Δnon-invasive values and Δinvasive values on 
four-quadrant plots with concordance rates and polar plot analysis (Figures 
25-31, Table 8) [112, 113]. In studies using thermodilution as the reference 
CO, concordance rates of 90-95% support good trending ability [112]. Unlike 
concordance rates, polar plot analysis assesses agreement not only in 
direction of change, but also for the magnitude of that change. The radial 
length of the polar vector represents the mean change in consecutive paired 
non-invasive and invasive measurements. The polar angle represents 
agreement of the magnitudes of change between the methods, and the mean 
polar angle, or angular bias, indicates how well calibrated the test method is 
with the reference method. The radial limits of agreement is the radial sector 
that contains 95% of data points (analogous to the 95% limits of agreement in 
Bland-Altman analysis) and the 30° angular concordance rate is the 
percentage of data points in the ±30° sector. Critchley and colleagues set 
acceptance limits for good trending ability of an angular bias of <±5°, radial 
limits of agreement of <±30°, and a 30° concordance rate of ≥95%. However, 
in the meta-analysis by Peyton and Chong [114], the authors suggest 
percentage limits of agreement should be increased from ±30% to ±45%, as 
there is a suggestion that in fact the precision error of thermodilution as a 
reference method is closer to ±30%. In addition, when methods of V̇O2 
measurement with Fick have been compared, an error of 25% has been 
recognised due to the random error inherent in the calculation [122].  To 
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reflect this, a priori, radial concordance rates of <±30o and <±45
o are reported 
in this study’s results. 
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Figure 25 Four-quadrant concordance plot and polar plot for changes in VO2 measured invasively compared to the GEM cart. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included. 
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Figure 26 Four-quadrant concordance plot and polar plot for changes in DO2 measured invasively and non-invasively. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included. 
 
 
104 
 
Figure 27 Four-quadrant concordance plot and polar plot for changes in CO measured with LiDCOrapid and the esCCO monitors. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included 
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Figure 28 Four-quadrant concordance plot and polar plot for changes in Hb measured arterially compared to the Pronto-7 monitor.  
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included. 
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Figure 29 Four-quadrant concordance plot and polar plot for changes in Hb measured central venously compared to the Pronto-7 monitor. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included. 
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Figure 30 Four-quadrant concordance plot and polar plot for changes in Hb measured arterially compared to central venously. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included 
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Figure 31 Four-quadrant concordance plot and polar plot for changes in O2 saturations measured arterially compared to the Pronto-7 monitor. 
Assessment for trending of data. In the left graph, the right upper and left lower quadrants the two technologies agree. The central square refers to the 10% exclusion zone. 
The concordance refers to the percentage of data points in these quadrants. On the right graph mean angular bias is represented by the red line and the radial limits of 
agreement are bounded by the light blue lines. The dashed line represents the ±45
o
 angular concordant sector. A 10% central exclusion zone is included. 
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Figures 32-38 show the temporal patterns of post-operative V̇O2 and DO2 when 
measure invasively and non-invasively for each individual patient. As the timing 
of each paired measurement was not consistent between individuals a 
population mean pattern is not possible to achieve. Although not formally 
tested, Figures 32-38 do appear to demonstrate that non-invasive temporal 
patterns mirror those of the invasive measurements, and that there is a 
reduction in both V̇O2 and DO2 in the early post-operative period followed by a 
subsequent increase. 
 
A number of individual paired readings were not possible in eleven individuals. 
Table 9 lists the reasons for the missed measurements. 
 
Reason for missed reading Readings affected Number of 
readings affected 
Number of 
patients 
 
No arterial line trace/in situ 
 
All invasive readings 7 3 
 
Pronto-7 reading not possible 
 
Non-invasive Hb/O2 sats 
(non-invasive DO2 
calculation) 
6 1 
 
Patient withdrew from study 
 
All readings 5 1 
 
Patient discharged from Critical care 
 
All readings 3 2 
 
Patient refused reading 
 
All readings 2 1 
 
Patient with OSA requiring CPAP 
 
All readings 2 1 
 
Leak from GEM tubing 
 
Non-invasive VO2 2 2 
Table 9 Reasons for missed readings in validation study 
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Figure 32 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 33 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 34 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 35 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 36 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 37 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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Figure 38 Individual patient patterns of post-operative VO2 and DO2 measured invasively and non-
invasively. 
Each data point represents one measurement. Time 0 = end of surgery. First measurement variable time 
post-operative. 
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3.4 DISCUSSION 
To our knowledge, this is the first study to evaluate the ability of the GEM 
metabolic cart, and the esCCO and Pronto-7 derived variables, to measure and 
track changes in post-operative V̇O2 and DO2. As our reference technique we 
used variables obtained from the LiDCOrapid CO monitor, which is established 
in clinical practice and provides an estimated/nominal CO based on the 
PulseCO algorithm [99], and has been shown to be within acceptable limits of 
agreement with intermittent thermodilution via PAC [99, 101, 102] combined 
with arterial and central venous blood gas analyses, and calculated V̇O2 and 
DO2 according to the Fick equation (Fick V̇O2 and invasive DO2).  
 
We found that the mean bias (±precision) between GEM V̇O2 and Fick V̇O2 was 
68.16 (±83.51) ml.min-1, demonstrating that the GEM gave a systematically 
lower V̇O2 than the minimally invasively calculated Fick V̇O2. Conversely, the 
mean bias (±precision) between non-invasive DO2 (NIDO2) and invasive DO2 
(IDO2) was -18.98 (±165.33) ml.min
-1, showing a small, but systematically 
higher DO2 when calculated from the non-invasive measurement techniques. 
Limits of agreement were wide for both V̇O2 and DO2 (-95.52 to 231.84 ml.min
-1, 
and -343.00 to 305.07 ml.min-1 respectively). The percentage error when 
comparing GEM V̇O2 and Fick V̇O2 was 66.3%, and 39.6% when comparing 
NIDO2 and IDO2. These findings suggest that GEM V̇O2 and Fick V̇O2, and 
NIDO2 and IDO2, are not interchangeable based on the criteria of Critchley and 
Critchley [111], who suggest a percentage error <30% is acceptable. 
 
In a clinical setting, trends of V̇O2 and DO2 have more relevance to patient 
management than absolute values. Trending ability was assessed with four-
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quadrant concordance and polar plot analysis (Figures 25 & 26, Table 8). When 
comparing GEM V̇O2 and Fick V̇O2, there is a four-quadrant concordance rate 
of 64.1%, a mean angular bias of -15.56o, radial limits of agreement of ±50o, 
and a 30o angular concordance rate of 60.0%. For DO2, these values are 
71.9%, 1.98o, ±48o, and 82.5% respectively. Based on the standards of 
Critchley and colleagues (who set acceptance limits for good trending ability of 
concordance rates of 90-95%, an angular bias of <±5°, radial limits of 
agreement of <±30°, and a 30° concordance rate of ≥95%) [112, 113], these 
methods demonstrate poor/moderate trending abilities. These limits were set 
based on Critchley and Critchley’s theoretical scatter expected in agreement 
when two methods of CO are compared, each with a precision of ±20%, with 
the reference method as thermodilution [111]. However, in their meta-analysis 
of 47 studies comparing four different methods for minimally invasive CO 
measurement with thermodilution, Peyton and Chong [114] found that none of 
the methods met Critchley and Critchley’s criteria, but that they all achieved 
limits of agreement that were very similar (41.3-44.5%) despite using different 
physical and physiological principles suggesting that a “fundamental limitation 
exists to the precision of agreement with a given reference standard like 
thermodilution that can be achieved in clinical practice”. They reasoned this was 
because the reference method (PAC derived CO via thermodilution) had a 
percentage error approaching ±30%, rather than the oft-quoted ±20%, and used 
the same mathematical theory applied by Critchley and Critchley to favour 
widening the acceptable percentage error in agreement to ±45%. Furthermore, 
when methods of V̇O2 measurement with Fick have been compared, an error of 
25% has been recognised due to the random error inherent in the calculation 
[122]. To reflect this, we have reported 45o angular concordance rates in our 
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polar plot analysis. These are 86.7% and 92.5% for GEM V̇O2 and NIDO2 
respectively, which may represent moderate/good trending ability when 
compared to our reference minimally invasive techniques. 
 
There is a lack of published data validating the GEM against Fick V̇O2, but 
laboratory performance tests for the GEM show a mean error of 0.3 ± 2.0% for 
the measurement of V̇O2 [94]. This compares favourably to the mean error of 4 
± 2.0% demonstrated by Takala et al. [124] for the DeltatracTM Metabolic 
Monitor (Datex-Ohmeda Inc.). Deltatrac is no longer commercially available, but 
has been considered as the standard reference tool in indirect calorimetry [96]. 
Furthermore, in their recent comparison study Kennedy and colleagues have 
shown GEM to be a reliable alternative to the Deltatrac based on measures of 
repeatability [95]. Previous studies comparing gas exchange methods with Fick 
V̇O2 have also concluded that the two methods are not interchangeable [122-
124, 128-133]. Whilst the majority report that Fick (calculated) V̇O2 was less 
than that measured directly, and explain this in terms of lung V̇O2 which is not 
included in the Fick calculation [123, 124, 128, 132-134], others show no 
difference between the two methods [135, 136], or similar results to the present 
study [130, 137]. No previous study has attempted to formally address the 
trending ability of any method of V̇O2 measurement, however, Stock and 
colleagues, despite rejecting Fick V̇O2 as a research tool due to it’s inaccuracy 
when compared to V̇O2 measured with a water-sealed spirometer, suggest that 
the direction of change in true V̇O2 is likely reflected by Fick V̇O2, and may be 
useful clinically [122]. 
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Fick V̇O2 and both IDO2 and NIDO2 are all calculated terms and so we have 
assessed the measurement of each variable (CO, Hb concentration, O2 
saturations) in terms of agreement and trending ability when compared to an 
accepted reference standard. The esCCO monitor had a mean bias of -
0.04L.min-1, a precision of ±1.08L.min-1 with wide 95% limits of agreement of -
2.15 to 2.07L.min-1, and a percentage error of 36.5% when compared to 
LiDCOrapid. This indicates that the two methods are not interchangeable in 
terms of absolute values. However, the trending ability of esCCO compared to 
LiDCOrapid is very good, as indicated by four-quadrant concordance rates of 
91.7% and polar plot analysis giving a mean angular bias of -0.43o radial limits 
of agreements of ±27o, and 30o and 45o angular concordance rates of 95% and 
97.5% respectively. LiDCOrapid interrogates the arterial trace from a standard 
arterial line (typically in the radial artery) and provides an estimated/nominal CO 
based on the PulseCO algorithm [99]. LiDCOrapid has been shown to be within 
acceptable limits of agreement with intermittent thermodilution via PAC [99, 
101, 102]. It has recently been used in 2 well-designed RCTs as the CO monitor 
to guide goal-directed fluid therapy [86, 88]. The esCCO is a novel non-invasive 
method for estimating continuous CO [138], and in a comparison to 
thermodilution derived CO Yamada et al. reported an acceptable bias of 
0.13L.min-1 and small limits of agreement of 0.04 to 0.22 L.min-1, but a 
percentage error of 54%. Others have questioned the clinical utility of the 
esCCO, with large limits of agreement in comparison studies with thermodilution 
and transthoracic echocardiography [138-140]. However, like the present study, 
Ishihara and colleagues demonstrated comparable trending abilities with 
currently available arterial waveform analysis methods such as the FloTrac/ 
Vigileo monitor [141]. 
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Bland-Altman analysis of Pronto-7 determined Hb concentrations and O2 
saturations demonstrate good agreement between both arterial and central 
venous Hb measurements and standard oximetry values with acceptable bias, 
precision and 95% limits of agreement, and percentage errors of <30% (Table 
6). Our statistical analysis, however, demonstrates the limitations of using both 
four-quadrant concordance plots and polar plot analysis for these 
measurements, as they are variables that would be expected to remain 
relatively stable even in the post-operative setting. This is reflected by the 
number of measurements (n) used in the analysis after the recommended 10% 
exclusion zone is instituted (to exclude small changes that might be expected 
due to random error [112]). In situations where there is significant expected 
blood loss, such as major neurosurgical procedures, the Masimo SpHb sensor 
(as used in the Pronto-7) has been shown to have good trending ability with 
arterial blood gas analysis [142]. Pronto-7 has also been shown to have similar 
accuracy as the HemoCue (HemoCue, Sweden) point-of-care device when 
compared with a laboratory haematology analyser in the outpatient setting, with 
bias ± standard deviation of -0.1 ± 1.1 g/dL and  -0.1 ± 1.6 g/dL respectively 
[106], and comparable accuracy in the trauma patients [107]. 
 
None of the methods we have used to measure V̇O2 or DO2 can be considered 
a ‘gold standard’. The poor agreement between the methods may be 
attributable to errors with either of the techniques themselves:  
Indirect calorimetry usually requires patients to be in a steady state [128, 129, 
143], which may limit its utility to track changes in V̇O2, however, the GEM was 
specifically designed to be used in either steady state or light exercise with its 
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mixing chamber method for the collection of expired gases, and has proven 
highly reliable in these settings [94]. We carried out readings with all patients in 
the supine position with a 30o head-up tilt. No change in their haemodynamic 
status was evident within 30 minutes of any reading and there was no calorific 
intake 1 hour prior to any readings. In canopy indirect calorimeters such as the 
GEM, high gas flows in excess of 40 L.min-1 are used to avoid CO2 
accumulation, resulting in dilution of expiratory gases, and the need to detect 
small differences in concentrations. Accuracy of O2 measurement is reduced as 
FiO2 increases due to smaller differences in inspired and expired O2 fractions. 
To mitigate against this we carried out all readings on room air (FiO2 = 0.21), 
with no patient de-saturating significantly. Any leaks from the system can also 
cause inaccuracies of gas collection. We had two readings abandoned due to 
system leaks (Table 9), which were identified following unexpectedly low V̇O2 
readings. According to the manufacturers recommendations, the GEM was 
calibrated after a 30-minute warm-up. Calibrations were also performed when 
the cart had been idle for more than 20 minutes or after 2 hours of continuous 
use. Monthly ethanol burning tests were performed as a quality check, and the 
manufacturer calibrated the mass flow meter annually. 
 
The precision of the Fick method for calculating V̇O2 and DO2 is dependent on 
the accuracy of the CO and arterial and venous oxygen content measurements. 
These variables all have their own measurement error, which may be within the 
acceptable range, but when combined in a calculation these errors may be 
propagated and substantially greater than the sum of those errors [144]. In 
particular, some of the assumptions made in our Fick calculation could 
 
 
123 
introduce inaccuracy: The amount of oxygen dissolved in arterial blood (0.023 x 
PaO2) was disregarded in the calculation, as PaO2 could not be determined 
non-invasively. In an average adult male with an Hb = 15 g/dL, an SaO2 = 
100%, a PaO2 = 13.3 kPa, and a CO = 5 l/min, the difference in CaO2 = 0.3 
ml/100ml (20.1 vs 20.4 ml/100ml), which equates to a difference in DO2 = 15 
ml/min (1005 vs 1020 ml/min), or a reduction of < 1.5%, which was deemed 
acceptable on pragmatic grounds. Furthermore, we chose 1.34 mL as the value 
of Huffner’s constant for the O2 combining capacity of Hb. Values between 1.31 
mL and the theoretical value of 1.39 mL have been used in other studies, which 
can introduce a variability of around 6% for calculated values of V̇O2 and DO2 
[132], and would obviously affect any comparisons made in the present study. 
In addition, we substituted central venous oxygen saturations (ScvO2) for mixed 
venous values in the Fick equation, which could potentially introduce further 
error into the calculation of our reference techniques. ScvO2 has been shown to 
correlate well with those of mixed venous saturations [103], therefore in the 
absence of mixed venous readings it was our only alternative to calculate V̇O2. 
We attempted to reduce any further measurement errors in our invasive 
techniques by minimizing delays in analysis, calibrating analysers carefully, 
using a single investigator to take measurements, and averaging those 
measurements after a period of acclimatization. This was at the expense of 
making each data point acquisition very labour intensive. 
 
When measuring post-operative V̇O2 and DO2, a variety of factors (institutional, 
device related, and patient specific) must be considered and influence the 
selection of the appropriate method, and clinicians must understand the 
underlying principles and inherent limitations of those methods. As is the case 
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with CO monitoring, an integrated approach is required, when the use of an 
invasive or a minimally or non-invasive technique is preferable (Figure 39). 
 
Figure 39 An integrative concept for the use of cardiac output (and V̇O2 and DO2) monitoring 
devices.  
(Adapted from Alhashemi et al. [145]. Indirect calorimetry is non-invasive 
  
 
 
125 
Conclusion 
 
Although there is a bias towards a lower V̇O2 and slightly higher DO2 with wide 
limits of agreements when measured non-invasively and these methods may 
lack precision when compared to currently available minimally invasive 
measurements, these techniques demonstrate moderate to good trending ability 
and have the advantage of being safe, totally non-invasive, reliable and 
convenient. Moreover, Fick calculations of V̇O2 and DO2 have the shared 
variables of CO and CaO2, which raises the possibility of a systematic 
methodological error as a consequence of mathematical coupling [144, 146, 
147], when supply dependency of O2 is being investigated. Therefore, these 
non-invasive techniques could be useful for the bedside monitoring of post-
operative V̇O2 and DO2 patterns of ward patients.  
 
The following chapter describes a further study into the feasibility of these non-
invasive measurement techniques of V̇O2 and DO2 in the perioperative setting 
and as pilot work examining the relationship between post-operative V̇O2 and 
complications in patients having contemporary major abdominal surgery.  
Ultimately non-invasive techniques might be useful as an early warning to 
determine which patients are developing “oxygen debt” [38], as a trigger to alter 
clinical care and potentially improve outcome. 
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Chapter 4 
 
 
CO2ST: THE COST IN OXYGEN OF SURGICAL TRAUMA – A 
FEASIBILTY STUDY OF THE NON-INVASIVE MEASURMENT OF 
OXYGEN DELIVERY AND CONSUMPTION AFTER MAJOR 
ABDOMINAL SURGERY 
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4.1 INTRODUCTION 
More than 80 years ago Cuthbertson measured V̇O2 by external spirometry 
after orthopaedic injuries or operations in six patients [49]. He found initial 
decreases in V̇O2 followed by increased V̇O2; he termed this pattern the “ebb 
and flow” of oxygen. Later Cournand et al. [148] described oxygen transport 
and haemodynamic patterns in traumatic shock, and reporting reductions in 
CO, body metabolism, and blood volume in severe shock. In addition, Clowes 
and Del Guercio [149] described increased CO after surgery when associated 
with sepsis. Subsequently, the temporal patterns of haemodynamic and 
oxygen transport variables have been described following elective surgery in 
survivors and non-survivors [14, 16, 150-152]. In these patients, cardiac index 
(CI), DO2 and V̇O2 were significantly higher in survivors than in non-survivors 
with comparable disorders. In 708 high-risk surgical patients, Shoemaker et 
al. demonstrated that survivors had greater postoperative increases in CI, 
DO2, V̇O2, and other haemodynamic variables than in the non-survivors [150], 
and that these variables were highly predictive of outcome. Indeed, several 
prospective studies, patient outcome was improved when “supra-normal” 
values, defined empirically by the median values of survivors, were attained 
early [14, 16, 150-152]. However, other studies showed no improvement in 
outcome by increasing DO2 during the late postoperative period after organ 
failure was established [153, 154].  
 
These studies used invasive techniques to measure and calculate V̇O2 and 
DO2; primarily the pulmonary artery catheter (PAC). Thus, these studies 
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included only those patients who were considered to be at sufficiently high 
risk to justify the insertion of a PAC and admission to a high dependency 
environment - in general those having surgery with a likelihood of extensive 
tissue trauma and fluid shifts, or those with co-morbidities severe enough to 
potentially impair their ability to generate a sustained increase in DO2). 
Consequently the pattern of postoperative V̇O2 and DO2 in fitter patients or 
those having less extensive body cavity surgery is not known. 
 
More recently major advances in peri-operative care have greatly reduced the 
risk of dying after surgery and complication rates (reflected in shorter length of 
stay). Recent studies suggest that the assumptions from previous studies may 
not hold – most less fit patients survive surgery and go home promptly [35] 
and goal directed therapy may not have the impact of previous studies [84, 
87, 92]. There is the strong possibility that modern care does not trigger as 
much of an inflammatory response as that seen previously and that patients 
do not need to develop the same alterations in V̇O2 and DO2. This was 
demonstrated in a recent small study of patients undergoing major vascular 
surgery using non-invasive techniques to determine V̇O2, where no rise in 
post-operative V̇O2 was observed [93].  
 
We have previously evaluated the GEM indirect calorimeter (GEM Nutrition, 
Daresbury, UK), the esCCO (Nihon Kohden, Japan) CO monitor, and the 
Masimo Pronto-7 SpHb device against currently available minimally invasive 
devices and demonstrated a bias towards a lower V̇O2 and slightly higher DO2 
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with wide limits of agreements when measured non-invasively (Chapter 3). 
These methods may lack precision but they demonstrate moderate to good 
trending ability and have the advantage of being safe, totally non-invasive, 
reliable and convenient. Therefore, we believe these techniques are useful for 
the bedside monitoring of post-operative O2 and DO2, especially in the Level 
1/0 ward setting [155].  
 
This study aims to test the feasibility of these non-invasive measurement 
techniques in a cohort of patients and to explore the temporal patterns of V̇O2 
and DO2 measured by these techniques, and their relationship with post-
operative complications, after contemporary major abdominal surgery. 
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4.2 METHODS 
For more detailed methods please refer to the earlier Methods chapter. This 
prospective observational feasibility study was conducted on a cohort of 42 
patients undergoing elective major colorectal surgery between December 
2014 and March 2015 at Derriford Hospital, Plymouth, UK. Ethical approval 
was obtained from the NRES Committee South West – Cornwall & Plymouth 
(ref: 14/SW/1109), and was registered on the ClinicalTrials.gov database 
(Identifier: NCT02238561). 
 
All patients scheduled for elective colorectal resections undergo a pre-
operative assessment at a dedicated clinic. During the conduct of the pre-
operative assessment, patients were provided with written information 
(Appendix 4) and invited to consider participation in the study. Written 
informed consent was obtained from all participants (Appendix 5). 
 
All interventions were at the discretion of the operating surgeon and/or 
consultant anaesthetist responsible for the patient. Mechanical bowel 
preparation (MBP) was avoided where possible, and those patients receiving 
MBP routinely received an intravenous infusion of 1-2L of isotonic crystalloid 
prior to arrival in the operating theatre. Standardised peri-operative care was 
provided by a dedicated colorectal surgical team, and critical care as 
appropriate, according to a well-established local ERAS pathway.  
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Baseline V̇O2 and DO2 measurements were made on the morning of surgery 
after admission to the pre-operative surgical admission unit. Post-operative 
measurements were taken at 1, 2, 4, 8, 12, 24, and 48 hours after the 
completion of surgery. All observations were made with patients lying in bed 
with a 30o head up tilt.  
V̇O2 measurement 
The GEM (GEMNutrition, Daresbury, UK) is an open-circuit flow-through 
indirect calorimeter. The compact bedside unit measures gas exchange 
volumes, respiratory quotient and energy expenditure. It does this by 
alternately measuring O2 and CO2 concentrations of inspired and expired air. 
Gas collection is via a comfortable transparent perspex hood placed over the 
patient’s head and chest (Figure 9). GEM is inaccurate above an FiO2 of 30%, 
and the system is incompatible with ventilators. Measurements were taken 
with the patient breathing room air (FiO2 = 21%), however, if the patient’s 
SpO2 fell below 90%, an FiO2 of 28% was employed. Further desaturation on 
28% O2 mandated abandoning the recordings at that time-point. Minute-by-
minute V̇O2 averages are displayed on a monitor and it typically takes a 
subject between 5 and 10 minutes to acclimatise and for the V̇O2 to settle to a 
baseline (ΔV̇O2 < 5% on 2 consecutive readings). This was followed by a 5-
minute recording period. A mean V̇O2 was then calculated for the 5-minute 
recording period. 
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DO2 measurement 
DO2 was calculated according to the following equation: 
   DO2 = CO x CaO2 
   CaO2 = (Hb x SaO2 x 1.34)  
The amount of oxygen dissolved in arterial blood (0.023 x PaO2) was 
disregarded in the calculation, as PaO2 could not be determined non-
invasively (see chapter 2.2.1). 
CO was measured using the esCCO (Nihon Kohden, Japan) monitor and an 
average calculated for the 5-minute GEM recording period. The esCCO 
monitor provides a real-time estimation of CO from pulse wave transit time i.e. 
the time interval between the R wave of the ECG and the arrival of the arterial 
pulsation wave at an oximeter probe placed on the finger.  
 
Hb and SaO2 were measured with the Pronto-7 pulse co-oximeter (Masimo 
Corp, Irvine, CA, USA) at the beginning and end of the GEM recording period 
and an average calculated. 
Post-Operative Morbidity Survey 
To explore the relationship between post-operative V̇O2 and complications in 
patients having contemporary major abdominal surgery, the severity of 
complications need to be graded. The Post-Operative Morbidity Survey 
(POMS) is a simple outcome scale and was designed to produce an easy and 
reliable method of prospectively recording the incidence of clinically important 
complications - specifically complications likely to keep a patient in hospital 
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[25, 115]. For patients who had been discharged prior to assessment, a day 5 
POMS score of 0 was assumed. Patients were then divided into 3 groups: 
those without major post-operative morbidity, as defined by a POMS day 5 
score = 0, those with major post-operative morbidity (POMS day 5 ≥1), and 
those who died within 30 days of surgery. 
 
Statistical analysis 
This is a pilot study to investigate the feasibility of performing these 
observations on the target population and a preliminary investigation of V̇O2 
and DO2 after surgery. Thus many of the analyses are exploratory and in our 
cohort of patients we did not expect to see statistically significant correlations 
between our measurements and outcomes. No power calculation was 
therefore performed. 
 
Oxygen requirement at each time point was estimated from the baseline pre-
operative V̇O2. This was corrected for the effects of temperature (which 
assumed a “metabolic activity increased or decreased 7 percent per degree 
Fahrenheit” [38], and was calculated as follows:  
 
corrected V̇O2 (V̇O2c) = V̇O2 x 10
-0.036667 x (98.6 – T), where T is the 
patient’s temperature in oF.  
 
Values were indexed to body surface area to allow comparisons to be made 
between groups. 
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The estimated V̇O2 deficit, or excess, at each time point was calculated (as 
previously described [38]) as the difference between the measured V̇O2 and 
the pre-operative baseline V̇O2 corrected for temperature. The net cumulative 
O2 balance at each given time-point was calculated as the area under the 
curve (AUC) described by the time - V̇O2 deficit/excess curve (Figure 16). This 
was calculated using the trapezium methodology.  
 
To determine if there was a difference in V̇O2, DO2, and cumulative O2 
balance between those patients who developed complications or not, we used 
a linear mixed model for repeated measures over time by group. This type of 
modelling is applicable to a repeated measures study in which there is 
unbalance in the study groups and makes it possible to prevent list-wise 
deletion due to missing data [116-118]. 
 
Data was analysed and graphs produced using Microsoft® Excel® for Mac 
2011 and SPSS® v23.0 (SPSS, Chigcago, Illinois, USA). We compared 
baseline characteristics using 2 or Student’s t-test as appropriate.  
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4.3 RESULTS 
4.3.1 Study Population 
Eighty-seven patients were screened during the study period between 
December 2014 and March 2015 (Figure 37). Seven patients were not for 
surgical intervention, and four patients were admitted as an emergency prior 
to their planned pre-operative assessment date. Of those who underwent pre-
operative assessment (n=76), twelve were not recruited due to an investigator 
not being available, seven patients declined participation (two of these were 
due to claustrophobia and one patient suffered panic attacks), and one patient 
had dementia and was therefore unable to consent. 
 
Fifty-six patients were recruited. Nine patients had their scheduled date of 
surgery after completion of the study (i.e. April 2015, or later). Three patients 
withdrew before commencement of the study. Six patients had measurements 
taken pre-operatively but subsequently withdrew (n=2), did not meet the 
eligibility criteria (n=2, post-operative ventilation, no resection performed), or 
had their operation cancelled (n=2). Therefore, thirty-eight patients were 
included in the analysis (Figure 40).  
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Figure 40 CO2ST Study population 
*Pre-operative measurements included in analysis 
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4.3.2 Patient Characteristics 
Seventeen patients made an uneventful recovery from surgery. Twenty 
patients developed complications as defined by POMS 1 on day 5 post-
operatively. One patient died 21 days post-operatively of a pulseless electrical 
activity (PEA) cardiac arrest after developing mechanical small bowel 
obstruction requiring further surgery.  
 
Patient demographic data and preoperative values according to patient group 
are shown in Table 10 and Table 11. There were no significant differences in 
age, male:female, or type of surgery (colonic vs. rectal) between those who 
developed complications or not. However, patients who developed 
complications had a significantly longer length of stay (13.9  5.0 vs. 6.9  
4.8, mean  SD, p = 0.0001), and were more likely to have had an open 
procedure (18/20 vs. 8/17, p = 0.004).  
 
There were no significant differences between survivors and those who 
developed complications in any measured pre-operative variable, although 
pre-operative DO2 values of those who developed complications tended to be 
lower than those who made an uneventful recovery (525.91  26.67 vs. 
599.06  30.35 ml.min-1.m-2, mean  SD, p = 0.07). 
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All Survived Survived with 
complications 
p  Died 
n 38 17 20 
  
1 
Age* 
67.5(13.7) 
range 36.6-90.7 
62.8(14.5) 
range 38.5-90.7 
71.0(12.4) 
range 36.6-87.3 
0.07 
 
75.8 
Sex (m:f) 22:16 9:8 12:8 0.67 
 
1:0 
LOS* (days) 
10.7(6.0) 
range 2-23 
6.9(4.8) 
range 2-22 
13.9(5.0) 
range 6-23 
0.0001 
 
21§ 
Procedure 
      
  Rectal** 22(6) 10(5) 11(1) 0.82 
 
1(0) 
          AR          11(4)         7(3)         4(1) 
   
          Hartmann's         8(1)         1(1)         6(0) 
  
    1(0) 
          Pan Proctocolectomy         2(0)         1(0)         1(0) 
   
          APER         1(1)         1(1) 
    
  Colonic** 16(5) 7(4)         9(1) 0.82 
  
          Right hemi         9(3)         4(3)         5(0) 
   
          Left hemi         2(0)         1(0)         1(0) 
   
          Ext Right hemi         2(1)         1(1)         1(0) 
   
          Ileo-caecal resection         2(0)         1(0)         1(0) 
   
          Subtotal         1(1) 
 
     1(1) 
   
  Laparoscopic 11 9 2 0.004 
 
0 
 
Table 10 Demographic data of survivors, survivors with complications and non-survivor 
*Values are mean (SD). **Values are total (number laparoscopic). Data was compared with Student’s t-test or 
2
 test as appropriate.  
§
Patient died on day 21. LOS: length of 
stay
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 Survived Survived with 
complications 
p  Died 
n 17 20   1 
VO2 (ml.min
-1.m-2) 122.62 (3.49) 117.31 (3.74) 0.31 
 
109.77 
DO2 (ml.min
-1.m-2) 599.66 (30.35) 525.91 (26.67) 0.07 
 
444.37 
BSA (m2) 1.93 (0.05) 1.91 (0.04) 0.76 
 
2.19 
CI (L.min-1.m-2) 6.56 (0.35) 5.91 (0.32) 0.17 
 
5.67 
Hb (g.L-1 ) 137.06 (4.32) 132.60 (4.23) 0.47 
 
133.00 
SpO2 (%) 96.06 (0.40) 95.98 (0.46) 0.89 
 
96.00 
Temp (oC) 36.6 (0.10) 36.7 (0.09) 0.59 
 
36.70 
 
Table 11 Pre-operative values of survivors, survivors with complications and non-survivor 
Values are mean (SD). Data was compared with student’s t-test.
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4.3.3 Post-operative V̇O2 and DO2 
The patterns of post-operative V̇O2 and DO2 are shown in Table 12 and 
Figures 41 and 42. The linear mixed model found that V̇O2 is suppressed in 
the immediate post-operative period and does not rise back to pre-operative 
levels until more than 4 hours post-operatively (p <0.001). There was no 
difference in the temporal pattern between survivors and those patients who 
developed complications (p = 0.882). These patterns are similar to those seen 
previously [38].  
 
The linear mixed model found no statistically significant temporal pattern to 
post-operative DO2, and no difference between groups (p = 0.459 and 0.156 
respectively). If the pre-operative DO2 values are excluded, there were still no 
statistically significant differences over time or between groups.  
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 Group  Mixed Model 
Analysis* 
Time Survived Survived with 
complications 
Died  Effect p
§
 
VO2 (ml.min
-1
.m
-2
) 
Pre-operative 122.6 (3.49) 
(n=17) 
117.3 (3.74) 
(n=20) 
109.8    
1 hour 
118.3 (8.02) 
(n=15) 
105.8 (5.61) 
(n=17) 
96.1 
   
2 hours 
111.6 (6.34) 
(n=17) 
111.9 (4.86) 
(n=19) 
64.9 
 
Group 0.882 
4 hours 
125.5 (5.76) 
(n=17) 
124.6 (4.82) 
(n=18) 
148.1 
   
8 hours 
122.1 (4.91) 
(n=16) 
126.3 (5.37) 
(n=18) 
148.0 
 
Time <0.001 
12 hours 
126.6 (5.82) 
(n=16) 
128.5 (4.48) 
(n=19) 
150.4 
   
24 hours 
130.7 (5.41) 
(n=17) 
129.9 (7.39) 
(n=19) 
 
   
48 hours 
133.6 (3.58) 
(n=13) 
140.6 (7.56) 
(n=13) 
 
   
DO2 (ml.min
-1
.m
-2
) 
Pre-operative 599.7 (30.35) 
(n=17) 
524.9 (26.67) 
(n=20) 
444.4    
1 hour 
510.7 (36.46) 
(n=16) 
466.4 (20.16) 
(n=18) 
299.9 
   
2 hours 
520.34 (33.29) 
(n=17) 
427.1 (19.56) 
(n=19) 
388.6 
 
Group 0.156 
4 hours 
505.2 (30.84) 
(n=17) 
446.8 (19.79) 
(n=19) 
383.9 
   
8 hours 
436.8 (28.23) 
(n=16) 
438.5 (20.15) 
(n=19) 
455.4 
 
Time 0.459 
12 hours 
433.2 (20.33) 
(n=16) 
424.62 (19.75) 
(n=19) 
355.6 
   
24 hours 
485.5 (25.99) 
(n=17) 
450.3 (29.55) 
(n=18) 
 
   
48 hours 
498.4 (34.41) 
(n=14) 
507.6 (23.63) 
(n=13) 
 
   
Table 12 VO2 and DO2 patterns by group and results of mixed model analysis 
Values are mean (SEM). *Analysis compared survived and survived with complications groups only.     
§
p values associated with Type III tests of fixed effects. 
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Figure 41 Serial measurements of mean V̇O2. Time 0 = pre-operative values. Error bars are SEM. Survived n=17, survived with complications n=20, died n=1. 
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Figure 42 Serial measurements of mean DO2. Time 0 = pre-operative values. Error bars are SEM Survived n=17, survived with complications n=20, died n=1. 
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4.3.4 Post-operative oxygen balance 
The temporal patterns of cumulative O2 deficit or excess in the immediate 
post-operative period for survivors, survivors with complications and the non-
survivor are shown in Table 14 and Figure 43. Linear mixed modelling 
demonstrated that patients developed an oxygen debt in the immediate post-
operative period, but that this was subsequently “paid off” and became an O2 
excess, p = 0.002. However, there was no statistically significant difference in 
this pattern between survivors and survivors with complications, p = 0.731.  
 
Table 13 shows the mean (SEM) of the O2 deficit at its maximum and the 
duration of the O2 deficit for each of the patient groups. The latter represents 
the time that the net cumulative V̇O2 became positive, indicating that any 
“oxygen debt” had been repaid.  
 
 Survived Survived with 
complications 
p  Died 
Max O2 deficit (L.min
-1
.m
-2
) 1.04 (0.83) 0.78 (0.38) 0.775  2.15 
Time to net cumulative 
positive V̇O2 (hrs) 
13.41 (4.51) 5.79 (2.43) 0.154 
 
4.94 
Table 13 Post-operative tissue oxygen deficit 
Values are mean (SEM). Data was compared with Student’s t-test. 
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 Group  Mixed Model 
Analysis* 
Time Survived Survived with 
complications 
Died  Effect p
§ 
Net cumulative O2 balance (L.min
-1
.m
-2
) 
1 hour 
-0.16 (0.17) 
(n=17) 
-0.33 (0.15) 
(n=20) 
-0.41    
2 hours 
--0.56 (0.44) 
(n=17) 
-0.78 (0.39) 
(n=19) 
-1.76 
   
4 hours 
-1.04 (0.83) 
(n=17) 
-0.58 (0.83) 
(n=19) 
-2.15 
 
Group 0.731 
8 hours 
-0.88 (1.45) 
(n=17) 
1.52 (1.96) 
(n=19) 
7.03 
   
12 hours 
-0.63 (2.20) 
(n=17) 
3.94 (3.04) 
(n=19) 
16.49 
 
Time 0.002 
24 hours 
3.69 (4.19) 
(n=17) 
12.50 (5.85) 
(n=19) 
 
   
48 hours 
16.09 (8.89) 
(n=13) 
40.11 (16.89) 
(n=13) 
 
   
Table 14 Net cumulative oxygen balance patterns by group and results of mixed model analysis 
Values are mean (SEM). *Analysis compared survived and survived with complications groups only.      
§
p values associated with Type III tests of fixed effects. 
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Figure 43 Net cumulative oxygen balance for survivors, survivors with complications and non-survivor. Error bars are SEM
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4.3.5 Missing data 
Table 15 lists the reasons for any missed readings. There were 20 missed V̇O2 
readings and 16 missed DO2 readings. Only 5 were due to technical reasons 
(leak from GEM system, n=4, poor SpHb trace, n=1). The most common 
reading missed was at 48 hours post-operatively (n=11), followed by 1-hour 
post-operative (n=5), 8-hours (n=2), the remaining time points had one reading 
missed each. All readings were carried out with an FiO2 = 0.21, with no 
instances of patients desaturating <90%. No complications were recorded that 
could be attributed to the protocol of the study. 
Reason for missed reading Readings affected Number of 
readings affected 
 
Leak from GEM system 
 
VO2 4 
 
Vomiting at time of reading 
 
All readings 4 
 
Significant nausea requiring 
intervention 
 
All readings 4 
 
Not recorded 
 
All readings 2 
 
Patient withdrawn by clinical team 
 
All readings 2 
 
No investigator 
 
All readings 
 
2 
 
 
Poor SpHb trace on Pronto-7 
 
 
Hb.SpO2, DO2 
 
 
1 
 
 
Delay in patient arriving to recovery 
 
 
All readings 
 
1 
 
Patient discharged  home before 
reading 
 
All readings 1 
 Table 15 Reasons for missed readings in feasibility study 
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4.4 DISCUSSION 
It is safe and feasible to use the GEM indirect calorimeter, the esCCO CO 
monitor and the Masimo Pronto-7 SpHb device to measure V̇O2 and DO2 pre-
operatively and post-operatively in patients undergoing elective colorectal 
resections. These measurements can be used to calculate estimated post-
operative “oxygen debt” in these patients. Although not significantly different in 
this small feasibility study, there appears to be distinct patterns of V̇O2 and DO2 
after contemporary abdominal surgery in those patients who develop 
complications, as defined by POMS, or not which would confirm the “ebb and 
flow” of oxygen previously described [49, 148, 149]. However, the magnitude 
and direction of change of these O2 transport variables do not follow those of 
previous studies resulting in contemporary patterns of net cumulative O2 debt 
that differ from those previously described [38]. 
Patient safety is of paramount importance when any device is used in a novel 
way. There were no adverse events that could be attributed, either directly or 
indirectly, to the protocol of the study. Significantly no patients desaturated 
below 90% during any of the readings. Half (11/22) of missed readings were at 
the 48-hour time-point which questions the validity of taking readings at this 
time in future studies, however, this is in the context of 296 possible readings. 
Technical reasons accounted for 5 missed readings. In conjunction with a low 
refusal to participate rate (Figure 40), these results support the feasibility of the 
protocol for post-operative measurement of V̇O2 and DO2 in patients following 
colorectal surgery. 
In seminal papers, that influenced much subsequent research into goal directed 
therapy and latterly assessment of patients’ pre-operative functional capacity, 
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Shoemaker et al. described an increase in V̇O2 in high-risk patients after major 
surgery and presented evidence that the inability to meet this demand, was 
associated with severe post-operative complications and mortality [14, 38]. 
Using the pulmonary catheter and the reverse Fick equation, they estimated 
patients` postoperative V̇O2 requirement (using their measured preoperative 
baseline V̇O2 corrected for temperature) and suggested that oxygen deficit was 
present when this figure exceeded measured V̇O2. The temporal pattern of 
post-operative oxygen deficit appeared to differ according to whether patients 
survive, develop complications or not. Shoemaker used these observations to 
design an intervention involving manipulation of the cardiovascular system by 
fluid therapy and drugs to ensure adequate post-operative DO2 (later called 
Goal Directed Therapy, GDT), which appeared to dramatically improve clinical 
outcomes in the setting of high risk surgery [14, 34, 38]. More recently, studies 
looking at the role of GDT and functional assessment of patients’ aerobic fitness 
suggest that Shoemaker’s assumptions may not hold - most less fit patients 
survive surgery and go home promptly [35] and GDT may not have the impact 
of previous studies [84, 87, 88, 92, 93]. This is further supported by the current 
study that appears to show a different pattern of post-operative net cumulative 
O2 debt to that previously described. We describe post-operative V̇O2 and DO2 
that is suppressed in the immediate post-operative period, not rising to at or 
above baseline values until at least 4 hours post-operatively. This questions the 
central tenet of the GDT paradigm and shows how as yet unidentified 
mechanisms might contribute to reducing the burden of surgical critical illness 
[30]. One must consider heart failure as a potential cause of these initial low 
values given its prevalence in the aging population and is a leading cause of 
post-operative morbidity and mortality [12]. However, finding this would be 
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unusal in an entire study population as in the present study group means are 
presented. It is more likely that rather than a population-based approach to 
targeting DO2 to predefined values that a more individualised patient approach 
is likely to be optimum [81]. In a recent randomised controlled trial of targeted 
post-operative DO2 in high-risk surgical patients to their individual pre-operative 
DO2 value (POM-O), Ackland et al. demonstrated that achievement of 
preoperative oxygen delivery soon after major surgery is associated with a 
reduction in early postoperative morbidity, yet this occurred irrespective of 
additional postoperative haemodynamic manipulation over and above standard 
of care [30]. It may be that what affects clinical outcomes is care being closely 
applied and monitored by diligent personnel, rather than monitors and 
algorithms to target DO2 per se [88]. 
 
This study was designed to investigate the feasibility of performing these 
observations on the target population, and therefore sample size calculations 
were not performed. Consequently, interpretation of any of our results should be 
made with caution. The validity and limitations of our techniques to measure 
post-operative V̇O2 and DO2 has previously been discussed (see 3.4 
Discussion). We did not record heart rate (HR) in this study In retrospect, our 
failure to record HR is important as an increase in peri-operative HR has been 
linked to prolonged length of hospital stay after major surgery [156]. A change 
to the timing of baseline measurements (either in the anaesthetic room 
immediately pre-operatively, or alternatively at the pre-operative assessment 
clinic at patient enrolment) could reduce this bias. The post-operative DO2 
pattern of the non-survivor could indicate that there may be a critical threshold 
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of DO2 in the immediate post-operative period below which heralds the 
development of severe morbidity  mortality ensues.  
We chose as a secondary endpoint the development of post-operative 
complications as defined by a POMS 1 on day 5 following surgery. The choice 
of a categorical measure of post-operative complications may be flawed. The 
POMS is a binary measure of the presence of complications, which reduced the 
discriminatory power. It has been well validated in elective major surgery, with 
good inter-observer agreement and with the advantage that it should capture 
the presence of morbidity on any given day, which is of sufficient severity to 
require continued hospital admission [25, 115]. A POMS score performed on 
Day 5 is likely to be discriminative between patients who are recovering well, 
and those who are developing complications. However, in rectal surgery, POMS 
on day 5 may be too early to differentiate between those recovering well and 
not, as it has been shown that a positive POMS on day 15 after surgery was 
predictive of an increased mortality risk, whereas positive POMS on day 5 was 
not [157]. This raises the possibility that any meaningful comparison between 
the patterns of post-operative V̇O2 and DO2 according to the development of 
complications or not seen in previous work, the present study and any further 
work is flawed. Other measures of post-operative complications are equally 
problematic. The Clavian-Dindo classification system has enjoyed widespread 
acceptance as a measure [158]. However, this scale fails to discriminate well 
between serious and relatively minor complications. For example, intestinal 
ileus can be classified as Grade 2 whether it is treated with pro-kinetic drugs or 
total parenteral nutrition on the basis that both represent “pharmacological 
treatment”.  
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Conclusion 
The non-invasive measurement of V̇O2 and DO2 using the GEM indirect 
calorimeter, the esCCO CO monitor and the Masimo Pronto-7 SpHb device is 
safe and feasible in patients after major abdominal surgery. These 
measurements can be used to calculate estimated post-operative “oxygen debt” 
in these patients. Although not significantly different in this small study, there 
appears to be distinct patterns of V̇O2 and DO2 after contemporary abdominal 
surgery in those patients who develop complications, as defined by POMS, or 
not. Contemporary patterns of net cumulative O2 debt appear to differ from 
those previously described [38]. 
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Chapter 5 
 
 
DISCUSSION 
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This chapter summarises the discussion points arising in Chapters 3 & 4 and 
attempts to place the contents of this thesis in the context of contemporary 
peri-operative practice. 
 
5.1 STUDY FINDINGS 
 
Despite the bias and wide limits of agreements  the GEM indirect calorimeter, 
the esCCO CO monitor and the Masimo Pronto-7 SpHb device, techniques 
demonstrate moderate to good trending ability when compared to currently 
utilised minimally invasive monitors and have the advantage of being safe, 
totally non-invasive, reliable and convenient. Therefore, non-invasive 
techniques could be useful for the bedside monitoring of post-operative V̇O2 
and DO2 patterns of both high-risk and “standard” patients in the critical care 
setting and on the wards.  
 
It is safe and feasible to use the GEM indirect calorimeter, the esCCO CO 
monitor and the Masimo Pronto-7 SpHb device to measure V̇O2 and DO2 pre-
operatively and post-operatively in patients undergoing elective colorectal 
resections. These measurements can be used to calculate estimated post-
operative “oxygen debt” in these patients. Although not significantly different 
in this small study, there appears to be distinct patterns of V̇O2 and DO2 after 
contemporary abdominal surgery in those patients who develop 
complications, as defined by POMS, or not. Contemporary patterns of net 
cumulative O2 debt appear to differ from those previously described.  
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5.2 STUDY IMPLICATIONS 
5.2.1 Measuring V̇O2 Post-operatively 
 
There is considerable historical evidence that V̇O2 measured with gas 
exchange methods is not interchangeable with V̇O2 derived from the reverse 
Fick equation, and that due to inaccuracies in measurements of CO and the 
oxygen content of arterial and mixed venous blood, Fick V̇O2 should be used 
with caution when clinical decisions are based on its interpretation [122-124, 
128-133]. Despite this, over the last 3 decades Fick V̇O2 has been the 
accepted standard in research studies, and clinical practice, due to the 
cumbersome nature and other technical limitations of the available gas 
exchange methods [123, 124]. More recently, technological improvements 
have meant that metabolic carts are more compact and are able to be used at 
the bedside or incorporated into ventilator circuits, to enable clinicians to 
measure gas exchange and estimate energy expenditure in patients on 
general wards or the critical care setting [94, 96, 159].  
 
Our studies confirm this difference between measured and Fick V̇O2. They 
also demonstrate the acceptability to both patients and clinical staff of the 
GEM indirect calorimeter in the post-operative setting. Moreover, they show 
that the GEM is able to track changes in post-operative V̇O2. Furthermore, by 
decoupling the calculation of V̇O2 from DO2 (Fick calculations of V̇O2 and DO2 
have the shared variables of CO and CaO2), by using independent 
measurements, this overcomes the possibility of a systematic methodological 
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error as a consequence of mathematical coupling [144, 146, 147] when 
supply dependency of O2 is being investigated [160]. 
 
As previous stated, Shoemaker’s seminal papers describing the increase in 
V̇O2 in high-risk patients after major surgery and evidence that the inability to 
meet this demand, was associated with severe post-operative complications 
and mortality [14, 38]. He demonstrated  differing temporal patterns of post-
operative oxygen deficit according survivors, and those who developed 
complications or not. This developed into the first of many GDT interventions 
which appeared to dramatically improve clinical outcomes in the setting of 
high risk surgery [14, 34, 38]. However, more recently, studies looking at the 
role of GDT and functional assessment of patients’ aerobic fitness suggest 
that Shoemaker’s assumptions may not hold [35],[84, 87, 88, 92, 93]. This is 
further supported by the current study that appears to show a different pattern 
of post-operative net cumulative O2 debt to that previously described. To 
illustrate this the O2 deficit/excess curves from both studies are compared in 
Figure 44. 
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Figure 44 Comparison of Net cumulative O2 balance graphs, current study compared with Shoemaker et al. (1992) [38]. 
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5.2.1 Measuring DO2 Post-operatively 
 
DO2 is the product of CO and CaO2. Traditionally these variables have been 
derived from the PAC. This device has fallen out of favour recently as it has a 
significant morbidity rate associated with its use and a RCT on the use of the 
PAC on the survival of high-risk surgical patients showed no benefit in terms of 
mortality rates [161]. The PAC-man trial [127] was a large pragmatic RCT in the 
general ICU population and again failed to demonstrate any benefit form PAC 
use. It did also demonstrate no harm from its use either. In their commentary 
following the PAC-man trial Reade & Angus [162] recommend that “the clinician 
weigh carefully the perceived benefits, which may be largely intangible, against 
the small, but non-zero, risk of harm to the patient.” As a result there has been 
an expansion in novel CO monitoring devices. We describe the use of one such 
totally non-invasive CO monitor, the esCCO, in the perioperative setting. Like all 
such devices the esCCO has inherent limitations and these are discussed in 
Chapter 3 & 4, but primarily the fact that it is in essence a “black-box” that 
displays CO data from a proprietary algorithm, with an unpublished delay in 
recording and displaying the data which could adversely affect the comparisons 
made in this thesis. These concepts are equally true of non-invasive measures 
of Hb such as the Masimo Pronto-7.  
 
The place of GDT is controversial. GDT may not have the impact of previous 
studies [84, 87, 88, 92, 93]. There is still a debate of what should be the 
recommended baseline fluid therapy – of which some answers may be provided 
by a trial currently still undergoing patient recruitment, RELIEF [163]. This is a 
randomised controlled trial of restrictive vs. liberal fluid administration in more 
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than two thousand eight hundred patients undergoing elective major abdominal 
surgery. Further research will be required to identify patient groups who would 
most likely to benefit from GDT.  
 
Our results support a hypothesis that it is not the achievement of supra-normal 
values of DO2 that is important, rather it is avoiding a critical threshold of DO2 in 
the immediate post-operative period that might reduce morbidity and mortality. 
This might also support the inability of transfusion to improve outcomes in 
clinical trials – as the increase in DO2 is not contributing to any increase in VO2. 
5.3 STUDY LIMITATIONS 
 
The limitations of each study have been discussed fully in the relevant chapters, 
however, we outline below some of the limitations of our methodology and 
equipment used. The aim of this thesis was to perform original research to 
investigate the question “what is the V̇O2 after contemporary major abdominal 
surgery?” using non-invasive technology, and had two studies. Neither of the 
two studies had a power calculation performed to inform sample sizes. 
However, the sample size of the validation study was comparable to previous 
studies of agreement between methods of CO measurement. The second study 
was a small feasibility study, and not powered to detect any differences in the 
groups observed. 
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5.3.1 Limitations of equipment used 
 
Indirect calorimetry usually requires patients to be in a steady state [128, 129, 
143], which may limit its utility in the early post-operative period. We carried out 
readings with all patients in the supine position with a 30o head-up tilt. No 
change in their haemodynamic status was evident within 30 minutes of any 
reading and there was no calorific intake 1 hour prior to any readings. In canopy 
indirect calorimeters such as the GEM, high gas flows in excess of 40 L.min-1 
are used to avoid CO2 accumulation, resulting in dilution of expiratory gases, 
and the need to detect small differences in concentrations. Accuracy of O2 
measurement is reduced as FiO2 increases due to smaller differences in 
inspired and expired O2 fractions. To mitigate against this we carried out all 
readings on room air (FiO2 = 0.21), with no patient de-saturating significantly. 
Any leaks from the system can also cause inaccuracies of gas collection. We 
had six readings abandoned due to system leaks, which were identified during 
GEM calibration, or from unexpectedly low V̇O2 readings.  
 
The GEM is not compatible with ventilators. Thus we were unable to measure 
post-operative V̇O2 in any mechanically ventilated patients. There are other 
commercially available calorimeters that can be connected to an anaesthetic 
circuit [159] that would enable V̇O2 measurements in this group of patients, but 
these devices are expensive which limits their availability within a public health 
system for widespread clinical use. In addition clinicians caring for patients in 
intensive care have the option of invasive measures of DO2 and V̇O2. 
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A number of patients refused to participate in either of the studies due to 
claustrophobia and/or a reluctance to have the GEM hood placed over their 
heads. In those patients who did participate, 2 readings were abandoned due to 
patients not wanting to go under the hood due to nausea/vomiting. One patient 
was withdrawn from the validation study due to acute post-operative confusion.  
 
The Pronto-7 finger probe is sensitive to ambient light and movement and 
requires adequate blood flow to the finger to enable accurate readings. Only 
one reading was affected by a poor trace that was not remedial to hand 
warming or the use the proprietary opaque finger cover.  In one patient with a 
demyelinating disorder and who was unable to straighten their fingers we were 
unable to obtain Hb or O2 saturations at all and therefore unable to calculate 
non-invasive DO2. 
 
The esCCO device was very reliable and no abandoned readings were directly 
attributable to this device, however, some have questioned the clinical utility of 
the esCCO, with large limits of agreement in comparison studies with 
thermodilution and transthoracic echocardiography [138-140]. However, like the 
present study, Ishihara and colleagues demonstrated comparable trending 
abilities with currently available arterial waveform analysis methods such as the 
FloTrac/ Vigileo monitor [141]. 
 
During the conduct of the validation study we had to change our protocol due to 
an adverse event with the original invasive CO monitor used – the PiCCOplus 
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(see appendix 5). PiCCOplus utilizes arterial pulse contour analysis following 
calibration to measure CO and has acceptable agreement and bias in the 
measurement of cardiac output compared with intermittent thermodilution via a 
PAC provided a repeat calibration is performed after any major haemodynamic 
changes [98-100]. We changed to the LiDCOrapid CO monitor, which is 
uncalibrated and therefore might affect the accuracy of any CO measured 
invasively and used as our reference method. This is the Achilles Heel of the 
validation study as the LiDCOrapid does not measure absolute values of CO 
This clearly has implications for any conclusions drawn from any comparisons 
assumed to be accurate to the absolute values of CO. However, the 
LiDCOrapid is gaining widespread acceptance as a useful CO monitor and has 
been shown to be  useful to assess trending [164]. 
5.3.2 Post-operative complications 
Postoperative mortality is a robust endpoint but was sufficiently uncommon in 
this patient population to preclude its use as a primary outcome measure. Any 
choice of a categorical measure of post-operative complications may be flawed. 
As previously stated in Chapter 4, the POMS is a binary measure of the 
presence of complications, which reduced the discriminatory power. It has been 
well validated in elective major surgery, with good inter-observer agreement and 
with the advantage that it should capture the presence of morbidity on any given 
day, which is of sufficient severity to require continued hospital admission[25, 
115]. A POMS score performed on Day 5 is likely to be discriminative between 
patients who are recovering well, and those who are developing complications. 
However, in rectal surgery, POMS on day 5 may be too early to differentiate 
between those recovering well and not, as it has been shown that a positive 
POMS on day 15 after surgery was predictive of an increased mortality risk, 
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whereas positive POMS on day 5 was not [157]. This raises the possibility that 
any meaningful comparison between the patterns of post-operative V̇O2 and 
DO2 according to the development of complications or not seen in previous 
work, the present study and any further work is flawed.  
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5.4 CONCLUSIONS AND FUTURE WORK 
 
Much of the pre-operative optimisation work that is currently undertaken is 
founded on the physiological observations of Shoemaker [14, 38]. Much has 
changed both surgically and anaesthetically in the ensuing three decades: 2018 
is a post-PAC world with an emphasis on non-invasive techniques and 
enhanced recovery programmes. We have seen improved outcomes in terms of 
shorter lengths of stay and decreased post-operative morbidity and mortality. 
V̇O2 patterns after “modern” abdominal surgery are not known.  
 
We have shown that the GEM indirect calorimeter, esCCO monitor and Masimo 
Pronto-7 SpHb device can reliably measure and track changes in post-operative 
V̇O2 and DO2. Their use is safe and feasible in the post-operative setting, and 
the pattern of O2 transport variables appear to differ from that seen historically. 
Although we demonstrated an ebb and flow in post-operative V̇O2 similar to that 
seen previously [49], we did not show any significant difference in the temporal 
patterns of V̇O2, DO2 or net cumulative O2 balance. Any further work carried out 
using these non-invasive techniques to define the relationship between post-
operative patterns of V̇O2 and DO2 and the development of post-operative 
complications or not would ideally be in an appropriately powered study. The 
aim would be to determine if there is a difference in post-operative O2 debt in 
patients undergoing major abdominal surgery who make an uneventful recovery 
and those with post-operative morbidity and/or mortality, including any pre-
operative risk stratification and mode of surgery (open vs. laparoscopic). Future 
work might consider a comparison between survivors with and without 
complications based on base deficit and lactate at the end of surgery and pre-
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operative risk stratification with CPET variables e.g. AT. This might help identify 
which measured variable, either pre-, intra- or post-operative has the greatest 
discriminatory power to identify those patients who are not recovering well and 
who would benefit from increased monitoring and ultimately improve individual 
patients’ outcomes. However, the data obtained from the current study does not 
allow a power calculation to be performed. Further studies could prospectively 
help identify those patients developing a post-operative O2 debt as a trigger to 
alter clinical care (moving a patient to a critical care environment where more 
invasive monitoring and treatment is possible), and potentially improve 
outcome. 
 
The pattern of oxygen consumption after contemporary surgery described in 
these patients supports a hypothesis that GDT based care may not benefit most 
patients as their DO2 is well above that required for their V̇O2. It further suggests 
that a hypothesis describing why fit patients do well after surgery should not be 
based solely on V̇O2. 
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Patient Information Sheet 
A validation study of the non-invasive measurement of 
oxygen delivery and consumption after elective major 
abdominal surgery. 
 
 
You are being invited to take part in a research study. Before you decide whether or 
not you wish to take part, it is important that you understand why the research is 
being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. Please ask us if there is 
anything that is not clear or if you would like more information. Your participation in 
this study is entirely voluntary. 
 
 
Thank you for reading this. 
 
 
What is the purpose of the study?  
Major surgery can put a significant strain on the heart and lungs and may mean a 
long hospital stay. Some patients may have complications after major surgery. It is 
difficult to predict which patients this will happen to. In the past research confirmed 
that the body consumes more oxygen after surgery. Many patients went to an 
intensive care unit (ITU) and had invasive monitoring lines inserted into them to 
guide their treatment.  
Since this research was carried out there have been many advances in how we care 
for our patients before, during and after surgery. Fewer patients now have the 
“lines” and go to ITU than before but results are better. Patients with problems with 
their hearts and lungs, who might have done badly in the past, now do well. It may 
be that in 2013 surgery puts less stress on the body and we don’t see the increased 
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need for oxygen seen before, but as we are putting fewer monitoring lines in 
patients we can’t measure this easily. 
Our hospital has previously researched measuring oxygen requirements in children. 
They were asked to breath normally while their heads were in a large “goldfish 
bowl”, but we aren’t sure how well this technique will work in patients after major 
abdominal surgery. Likewise we have new technology which will allow us to 
estimate how well the oxygen is being delivered to the body by attaching the 
patient to normal monitors rather than using lines that go into the body. They stay 
outside the body and do not involve needles: they are attached either by sticky pads 
or a probe that comfortably fits on a finger or a cuff around the upper arm. They are 
not uncomfortable and they do not expose you to any risk. 
A key step before we can routinely employ these technologies is to see how well 
they agree with established methods. However, we can only do this in patients who 
are routinely looked after with the invasive monitoring lines in ITU after surgery. 
 
Why have I been chosen? 
You have agreed to have a planned operation following discussions with your 
surgeon. As a normal part of the anaesthetic during your type of operation all 
patients have monitoring lines inserted. For approximately 24 hours after your 
surgery, you will also normally be looked after in ITU. 
 
For this study we need 20 patients in Derriford Hospital to take part and you are 
invited to be one. 
 
Do I have to take part? 
No. It is entirely your decision as to whether you take part or not. Even if you do, 
you are free to withdraw at any time and without giving a reason and the standard 
of your on-going care will not be any less as a consequence. If you decide not to take 
part your usual healthcare will not be affected in any way 
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If you do decide to take part you will be asked to sign a consent form. You will be 
given a signed copy of the consent form for your own records. 
 
What will happen to me if I take part? 
Taking part in the study will neither delay nor speed up your surgery. All care 
provided and procedures carried out before, during and after your operation will be 
the same whether or not you take part in this study with the exception of below: 
 
1. On six occasions in the first 24 hours after your operation, your oxygen 
consumption will be measured using the GEM Hood (see picture). This is 
placed over your head and will be in place for around 10 minutes for each 
measurement. The hood is connected to a machine that measures how much 
oxygen you use whilst you are wearing it. You will have had a chance to see 
this at your pre-assessment and/or Cardiopulmonary Exercise Test (CPET) 
appointment. 
2. Whilst you are wearing the hood you will have some additional continuous 
monitoring:  Two simple probes attached to two of your fingers, a set of 
leads attached to your chest by sticky pads and a cuff attached around your 
upper arm.  
3. Another monitor (LiDCO Rapid) is attached to the line that you will already 
have in place in your artery. Using this line the LiDCO Rapid can give a great 
deal of information about the ability of the heart to pump efficiently.  
Samples of blood will be taken from the lines in your arteries and veins at 
the beginning and end of the measurement period to measure the oxygen 
and haemoglobin levels in your blood. 
 
What are the possible advantages and disadvantages of taking part? 
The care you receive before, during and after your planned surgery will not be 
affected by taking part in this study. Patients having your type of surgery will always 
have a monitoring line placed in an artery in order to monitor blood pressure. This is 
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usually placed in the artery at the wrist, but occasionally other arteries are used. The 
lines are specifically designed for use at these sites and we use an ultrasound 
scanner to identify the vessel to be used and verify that it is suitable.  
 
We fully expect some people might not like wearing the GEM hood after their 
operation. You will have had an opportunity to see it and try it on at your pre-
assessment appointment and hopefully this will help you decide whether you wish 
to take part in this study. However, you are free to withdraw from the study at any 
time. 
This study may help us to understand your condition better and help us to select the 
best treatment for people like you in the future. 
 
Will my taking part in this study be kept confidential? 
All the information collected about you during the course of the research will be 
kept for 5 years after the study finishes and is strictly confidential. Any published 
report of the research will not identify you.  
 
The GEM Hood. 
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What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researchers who will promptly do their best to answer your questions. We do 
not want you to worry.   
Should you have reason to complain about the way you have been treated at any 
stage during the study you can access the NHS patient advisory liaison service (PALS) 
who will be able to advise and help you: 
 
Patient Advice & Liaison Service               Monday to Friday 9.00 am to 
4.00 pm 
Patient Services Office            Telephone: 0845 155 8123 / 01752 
439884 Level 7          E-mail: 
plh-tr.PALS@nhs.net 
Derriford Hospital 
Plymouth  
PL6 8DH 
Harm – Legal Bits 
In the unlikely event you are harmed by taking part in this study, there are no 
special compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds to a legal action against Plymouth Hospitals 
NHS Trust. The normal National Health Service complaints mechanisms are still 
available to you. 
 
Who is organising and funding the research? 
The study is being undertaken as part of an MD research degree by Mr A Kimble 
(Surgical Research Registrar) at Plymouth University. Plymouth Hospitals NHS Trust 
(PHNT) has helped organize the study. Mr A Kimble, Dr G Minto and Dr R Struthers 
(Consultant Anaesthetists) are the principal investigators, in conjunction with 
Professor R Sneyd (Consultant Anaesthetist), and Mr K Hosie (Consultant Surgeon). 
All are employees of the PHNT.  
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We have a grant from the National Institute of Academic Anaesthesia to fund the 
study.  
 
What will happen to the results of this study? 
The results will be collected and analysed by the researchers. The data and any 
conclusions made may be presented at national academic meetings or published in 
a medical journal. If you wish to receive a summary of the results when the study is 
completed, please inform a member of the research team. This can be done at the 
time of signing the consent form or at any time via the contact details given below. 
Who has reviewed the study?  
The Plymouth & Cornwall Research Ethics Committee has given approval for this 
study. This is an ethical review body who act independently of the NHS but whose 
approval process runs concurrently with that of the Trust Research & Development 
Department. 
GP Notification 
Unless you specifically tell us not to, your GP will be sent a letter informing them of 
your participation in this study. 
 
What we need from you  
We would like you to take time to read and understand this information and then 
decide whether or not you would like to take part in the study. If you agree, then we 
will need to ask you to sign a consent form to confirm this in writing. We will not 
need you to do anything more after this.   
 
 
 
 
 
Thank you for taking the time to read this information sheet. 
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Should you have any queries about this study you may contact Mr Adam Kimble 
(Surgical Research Registrar) through the main hospital switchboard on 0845 
1558155 (bleep 89958), through Mr Hosie’s Secretary on 01752 763964 or via 
email a.kimble@nhs.net 
 
Thank you very much for your co-operation with this study. 
You will be given a copy of this sheet and a consent form to keep. 
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CONSENT FORM 
A validation study of the non-invasive measurement of oxygen delivery and consumption after 
elective major abdominal surgery.  
Cornwall & Plymouth REC Reference: 13/SW/0177 
R&D Reference: 13/P/083, UKCRN ID: 15072 
Mr A Kimble, Dr G Minto, Dr R Struthers, Prof R Sneyd, & Mr KB Hosie 
 
   Study ID Number            Hospital number         
Please initial the box if you agree:          
1. I confirm that I have read and understand the information sheet for the above study. I have had the opportunity to 
consider the information and received satisfactory answers to my questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, without giving any 
reason, without my medical care or legal rights being affected. 
3. I am willing to allow the researchers and individuals from regulatory authorities access to my medical records but 
understand that only information directly related to the study will be extracted and that strict confidentiality will 
be maintained. 
4. I agree to take part in the above study. 
5.  I agree to allow my GP and Surgeon to be informed of my participation in this study 
 
………………………………   ………………………………..   …………………………… 
Name of Patient/Witness  Signature    Date 
 
……………………………...   ………………………………..   …………………………… 
Name of person Authorized  Signature    Date 
to take consent 
 
A witness should sign above if the patient is unable to sign but has indicated their consent. 1 form to 
patient, 1 for the researcher and 1 to be kept in the hospital medical notes 
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Patient Information Sheet 
The Cost in Oxygen of Surgical Trauma (CO2ST) -  
A feasibilty study of the non-invasive measurement of oxygen 
delivery and consumption after elective major abdominal 
surgery. 
 
 
You are being invited to take part in a research study. Before you decide whether or 
not you wish to take part, it is important that you understand why the research is 
being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. Please ask us if there is 
anything that is not clear or if you would like more information.  Your participation 
in this study is entirely voluntary. 
 
 
Thank you for reading this. 
 
 
What is the purpose of the study?  
Major surgery can put a significant strain on the heart and lungs and may mean a 
long hospital stay.  Some patients may have complications after major surgery, but it 
is difficult to predict which patients this will happen to.  
In the past research confirmed that the body uses more oxygen after surgery. Many 
patients went to an intensive care unit (ITU) and closely monitored as part of their 
treatment. However, since this research was carried out there have been many 
advances in how we care for our patients before, during and after surgery.  Fewer 
patients go to ITU than before, and yet patients with problems with their hearts and 
lungs, who might have done badly in the past, now do well.  It may be that in 2014, 
surgery puts less stress on the body and we don’t see the increased need for oxygen 
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seen before, but because fewer people are admitted to ITU we can’t measure this 
easily. 
We have previously researched measuring oxygen requirements non-invasively in 
patients after surgery.  They were asked to breath normally while their heads were 
in a large “goldfish bowl” (The GEM Hood – see picture), and had some sticky pads 
placed on their chest, a monitor that fitted comfortably on a finger and a blood 
pressure cuff around the upper arm.  They are not uncomfortable and do not expose 
you to any risk.  
From this research we know these technologies work and are well tolerated by 
patients after surgery.  The purpose of the present study is to use these techniques 
to see if there is indeed an increase in the need for oxygen after major abdominal 
surgery in the 21st century. 
Why have I been chosen? 
Following discussions with your surgeon, you have agreed to have a planned 
operation involving your abdomen.  For this study we need 40 patients in Derriford 
Hospital to take part and you are invited to be one. 
 
Do I have to take part? 
No.  It is entirely your decision as to whether you take part or not.  Even if you do, 
you are free to withdraw at any time and without giving a reason and the standard 
of your on-going care will not be any less as a consequence.  If you decide not to 
take part your usual healthcare will not be affected in any way. 
 
If you do decide to take part you will be asked to sign a consent form.  You will be 
given a signed copy of the consent form for your own records. 
 
What will happen to me if I take part? 
Taking part in the study will neither delay nor speed up your surgery.  All care 
provided and procedures carried out before, during and after your operation will be 
the same whether or not you take part in this study with the exception of below: 
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1. On the morning of your surgery before you go to the operating theatre, and 
on 8 occasions in the 48 hours after your operation, the amount of oxygen 
you are using will be measured with the GEM Hood (see picture).  This is 
placed over your head and will be in place for around 10 minutes for each 
measurement.  The hood is connected to a machine that measures how 
much oxygen you use whilst you are wearing it.  You will have had a chance 
to see this at your pre-assessment and/or Cardiopulmonary Exercise Test 
(CPET) appointment. 
2. Whilst you are wearing the hood you will have some additional monitoring:  
Two simple probes attached to two of your fingers, a set of leads attached to 
your chest by sticky pads and a cuff attached around your upper arm.  
3. Your medical notes will be examined on the 5th day after your operation to 
ascertain if you have had any problems during your recovery from surgery. 
 
What are the possible advantages and disadvantages of taking part? 
The care you receive before, during and after your planned surgery will not be 
affected by taking part in this study.  
 
We fully expect some people might not like wearing the GEM hood after their 
operation.  You will have had an opportunity to see it and try it on at your pre-
assessment appointment and hopefully this will help you decide whether you wish 
to take part in this study.  However, you are free to withdraw from the study at any 
time. 
This study may help us to understand your condition better and help us to select the 
best treatment for people like you in the future. 
Will my taking part in this study be kept confidential? 
All the information collected about you during the course of the research will be 
kept for 5 years after the study finishes and is strictly confidential. Any published 
report of the research will not identify you.  
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The GEM Hood. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researchers who will promptly do their best to answer your questions. We do 
not want you to worry.   
Should you have reason to complain about the way you have been treated at any 
stage during the study you can access the NHS patient advisory liaison service (PALS) 
who will be able to advise and help you: 
Patient Advice & Liaison Service   Monday to Friday 9.00 am to 4.00 pm 
Patient Services Office   Telephone: 0845 155 8123 / 01752 
439884 
Level 7      E-mail: plh-tr.PALS@nhs.net 
Plymouth 
PL6 8DH 
 
 
 
192 
In the unlikely event you are harmed by taking part in this study, there are no 
special compensation arrangements.  If you are harmed due to someone’s 
negligence, then you may have grounds to a legal action against Plymouth Hospitals 
NHS Trust.  The normal National Health Service complaints mechanisms are still 
available to you. 
 
Who is organising and funding the research? 
The study is being undertaken as part of a Medical Doctorate (MD) research degree 
by Mr A Kimble (Surgical Research Registrar) at Plymouth University.  Plymouth 
Hospitals NHS Trust (PHNT) has helped organize the study.  Mr A Kimble, Dr G Minto 
and Dr R Struthers (Consultant Anaesthetists) are the principal investigators, in 
conjunction with Professor R Sneyd (Consultant Anaesthetist), and Mr K Hosie 
(Consultant Surgeon).  All are employees of the PHNT.  
We have grants from the charity Bowel Cancer West and the Plymouth Hospitals 
Charitable Fund to help fund the study.  
 
What will happen to the results of this study? 
The results will be collected and analysed by the researchers.  The data and any 
conclusions made may be presented at national academic meetings or published in 
a medical journal.  If you wish to receive a summary of the results when the study is 
completed, please inform a member of the research team.  This can be done at the 
time of signing the consent form or at any time via the contact details given below. 
Who has reviewed the study?  
The Plymouth & Cornwall Research Ethics Committee has given approval for this 
study.  This is an ethical review body who act independently of the NHS but whose 
approval process runs concurrently with that of the Trust Research & Development 
Department. 
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GP Notification 
Unless you specifically tell us not to, your GP will be sent a letter informing them of 
your participation in this study. 
 
What we need from you  
We would like you to take time to read and understand this information and then 
decide whether or not you would like to take part in the study.  If you agree, then 
we will need to ask you to sign a consent form to confirm this in writing. We will not 
need you to do anything more after this.   
 
Thank you for taking the time to read this information sheet. 
 
Should you have any queries about this study you may contact Mr Adam Kimble 
(Surgical Research Registrar) through the main hospital switchboard on 0845 
1558155 (bleep 89958), through Mr Hosie’s Secretary on 01752 763964 or via 
email a.kimble@nhs.net 
 
Thank you very much for your co-operation with this study. 
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CONSENT FORM 
The Cost in Oxygen of Surgical Trauma (CO2ST) -  
A feasibility study of the non-invasive measurement of oxygen delivery 
and consumption after elective major abdominal surgery. 
Cornwall & Plymouth REC Reference: 14/SW/1109 
R&D Reference: 14/P/123                                                                       
ClinicalTrials.gov Identifier: NCT02238561 
 
Investigators:  Mr A Kimble, Dr G Minto, Dr R Struthers, Prof R Sneyd, & Mr 
KB Hosie 
   Study ID Number           Hospital number 
 
Please initial the boxes below if you agree: 
1. I confirm that I have read and understand the information sheet (version 1.1, 3
rd
 Nov 2014) for the above 
study.  I have had the opportunity to consider the information and received satisfactory answers to my 
questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, without giving 
any reason, without my medical care or legal rights being affected. 
3. I am willing to allow the researchers and individuals from the study sponsors and regulatory authorities 
access to my medical records but understand that only information directly related to the study will be 
extracted and that strict confidentiality will be maintained. 
4. I agree to take part in the above study. 
5.  I agree to allow my GP and Surgeon to be informed of my participation in this study. 
 
……………………………… ……………………………….. …………………………… 
Name of Patient/Witness  Signature    Date 
 
……………………………... ……………………………….. …………………………… 
Name of person Authorized  Signature    Date 
to take consent 
 
A witness should sign above if the patient is unable to sign but has indicated their consent. 1 form 
to patient, 1 for the researcher and 1 to be kept in the hospital medical notes 
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During the early stages of A validation study of the non-invasive 
measurement of oxygen delivery and consumption after elective major 
abdominal surgery. NRES Committee South West - Cornwall & Plymouth: 
13/SW/0177, NIHR CRN 15072, there were two adverse events. The first 
event led to a change in the protocol to measuring the diameter of the 
brachial artery prior to insertion of the PiCCO arterial line. Following a second 
adverse event, that was felt to be related to the PiCCO arterial line, the study 
protocol was changed to use the LiDCOrapid as the source of CO 
measurement. The following documents relate to the reporting and outcomes 
of these adverse events with the MHRA, Pulsion (Munich, Germany, the 
manufacturer of PiCCO), and the local ethics committee. 
Documents included are: 
1. Report of Serious adverse event (DF19) 
2. Detailed report of Serious adverse event (DF19) 
3. Report of serious adverse event (DF28) 
4. Detailed report of serious adverse event (DF29) 
5. MHRA incident report 
6. Summary of Pulsion incident report 
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REPORT OF SERIOUS ADVERSE EVENT (SAE) 
 
 
1. Details of Chief Investigator 
 
Name: Adam Kimble 
Address: 
 
Colorectal Unit, Level 7, 
Derriford Hospital 
Plymouth 
Devon PL6 8DH 
Telephone: 01752 439004 
Email: a.kimble@nhs.net 
Fax:  
 
2. Details of study 
 
Full title of study: 
A validation study of the non-invasive 
measurement of oxygen delivery and 
consumption after elective major abdominal 
surgery. 
Name of main REC: 
Cornwall & Plymouth REC 
Main REC reference number: 
13/SW/0177 
Research sponsor: 
Plymouth Hospitals NHS Trust Research and 
Development Department 
Sponsor’s reference for this report: 
(if applicable) 
 
 
3. Type of event 
Please categorise this event, ticking all appropriate options: 
 
Death Life threatening Hospitalisation or  
prolongation of existing 
hospitalization  
 
Persistent or significant 
disability or incapacity 
Congenital anomaly  
or birth defect 
 
Other 
                                       T 
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Report of Serious Adverse Event v1. 16/10/2013 
4. Circumstances of event 
 
Date of SAE: 
27/11/2013 
Location: 
Penrose Ward, Derriford Hospital 
Describe the circumstances of 
the event: 
 
(Attach copy of detailed report if 
necessary) 
At 21:30 patient DF19 (SC) suddenly displayed 
signs of a right brachial artery occlusion which was 
deemed related to the arterial line that was placed 
in the brachial artery. The patient was reviewed by 
the vascular consultant on call and a brachial 
embolectomy performed under local anaesthetic 
with resultant restoration of blood flow to the right 
hand. (see attached full report) 
What is your assessment of the 
implications, if any, for the 
safety of study participants and 
how will these be addressed? 
The PiCCO monitor as used in the protocol for 
minimally invasive cardiac output monitoring 
requires either a brachial or femoral arterial line as 
per the manufacturers guidelines.  In this case , the 
patient`s brachial artery was narrower than usual 
due to an anatomical anomaly. We will add to the 
protocol that the investigator will ultrasound scan 
the brachial arteries prior to line insertion to ensure 
they are of adequate size for line insertion.  
 
5. Declaration 
 
Signature of Chief Investigator: Adam Kimble  
Print name: 
Adam Kimble 
Date of submission: 
28/11/2013 
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REPORT OF SERIOUS ADVERSE EVENT: DF19 
 
A validation study of the non-invasive measurement of oxygen delivery and 
consumption after elective major abdominal surgery. 
 
PHNT R&D ref: 13/P/083 
Cornwall & Plymouth REC Ref: 13/SW/0177 
The following events took place on 27 November 2013 and relate to patient SC 
hereafter identified as study number DF19. 
 
DF19 underwent an open resection of a colorectal liver metastasis on 27/11/2013 
after being consented into the study per-operatively. As part of the study protocol 
DF19 had a PiCCO arterial line inserted into her right brachial artery by the 
anaesthetist Dr G Minto (Co-investigator). Manufacturers instructions require that the 
brachial artery be used , and the device is specifically designed for this purpose. 
Placement was difficult, requiring more than one pass of the equipment, however 
onec placed the arterial line was used without any problems throughout the operation. 
Post-operatively DF19 was woken up and extubated and moved to Penrose high 
dependency unit as per local policy. All research equipment was set up as per 
protocol by the CI Adam Kimble. 
 
Prior to starting any measurements the nurse looking after DF19 took a sample of 
blood from the arterial line for analysis utilising standard precautions. Following this 
at approximately 19:00 hrs it was noted that the arterial trace suggested that the 
arterial line had become blocked, which is not uncommon. Various manoeuvres were 
tried to unblock the line including flushing with saline, aspirating the line and 
withdrawing the line by 0.5cm under asceptic conditions (carried out by the ITU/HDU 
doctor). Withdrawing the line was successful in establishing a normal arterial line 
trace on the monitor and enabling free flushing and aspiration of the line.  
 
Protocol then proceeded as usual. However (as recorded on the CRF) a 
thermodilution procedure was attempted (to calibrate the PiCCO monitor as per 
manufacturers guidelines and protocol). 15mls of cold normal saline is injected into a 
central venous line and the temperature change is sensed at the arterial line tip. On 
this occasion no temperature change was sensed and it was thought that this was 
due to a problem with the injection site sensor (situated on the central line in the 
neck). 2 further unsuccessful attempts were made at thermodilution – Dr Minto was 
called to assist with calibration of the equipment & arrived at approx 21:15. 
 
After reviewing all equipment Dr Minto agreed that the problem was probably due to 
the injection sensor which was exchanged for a new one. At 21:30 DF19 complained 
of sudden tingling of her right hand. Assessment showed a cooler hand (compare to 
the left), with no brachial, radial or ulnar pulses palpable. An occlusion of the right 
brachial artery was suspected and the arterial line removed. Further assessment with 
a handheld Doppler (a device that detects blood flow with sound waves) confirmed 
low blood flow in the right forearm and the on call vascular consultant, Mr Ioannis 
Vlachakis, was contacted at 2155.  
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Mr Vlachakis attended DF19 and agreed that there were signs of an acute brachial 
artery occlusion and suggested a brachial embolectomy be performed under local 
anaesthetic. DF19 consented to this. At surgery a brachial artery thrombus (blood 
clot) was identified and removed with resultant restoration of blood flow to the right 
hand. The vascular surgeon commented that the patient had an anatomical variant: a 
high bifurcation of the brachial artery, such that the calibre of the vessel at the elbow 
(site of placement) was narrower than is usual. This is a reasonably common 
anatomical variant.  Dr Minto has inserted more than 2000 arterial lines in clinical 
practice (although most are  done in the radial artery according to manufacturer 
guidelines of different systems) and not seen this complication before.  
 
Post-operative assessment of the right hand did not demonstrate any obvious 
problems with any of the blood vessels, nerves or muscles and DF19’s symptoms 
had all resolved.  The clinical condition of the circulation has returned to normal with 
no sequelae.  
 
The PiCCO arterial line was placed according to manufacturers guidelines, but due to 
a relativelty common anatomical variant, caused temporary injury requiring a 
procedure.  This anatomical variant can be excluded by targeted ultrasound 
examination prior to insertion (to confirm that the artery is large enough to safely 
admit the arterial catheter, and an alternative insertion site (femoral) is available). 
The investigating team will amend the protocol such that confirmation on ultrasound 
of an adequate calibre brachial artery is required prior to use of the brachial artery.  
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Report of Serious Adverse Event v1. 16/10/2013 
 
 
 
REPORT OF SERIOUS ADVERSE EVENT (SAE) 
 
 
1. Details of Chief Investigator 
 
Name: Adam Kimble 
Address: 
 
Colorectal Unit, Level 7, 
Derriford Hospital 
Plymouth 
Devon PL6 8DH 
Telephone: 01752 439004 
Email: a.kimble@nhs.net 
Fax:  
 
2. Details of study 
 
Full title of study: 
A validation study of the non-invasive 
measurement of oxygen delivery and 
consumption after elective major abdominal 
surgery. 
Name of main REC: 
Cornwall & Plymouth REC 
Main REC reference number: 
13/SW/0177 
Research sponsor: 
Plymouth Hospitals NHS Trust Research and 
Development Department 
Sponsor’s reference for this report: 
(if applicable) 
 
 
3. Type of event 
Please categorise this event, ticking all appropriate options: 
 
Death Life threatening Hospitalisation or  
prolongation of existing 
hospitalization  
 
Persistent or significant 
disability or incapacity 
Congenital anomaly  
or birth defect 
 
Other 
                                       T 
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Report of Serious Adverse Event v1. 16/10/2013 
4. Circumstances of event 
 
Date of SAE: 
06/01/2014 
Location: 
Penrose Ward, Derriford Hospital 
Describe the circumstances of 
the event: 
 
(Attach copy of detailed report if 
necessary) 
At 17:30 patient DF28 (GM) complained of an ache 
in his left arm. The left arm was cooler than the right 
but all pulses were present. Given a previous SAE 
relating to brachial artery catheters requiring an 
embolectomy, to prevent a further SAE the brachial 
artery catheter was removed. (Please see detailed 
report attached) 
What is your assessment of the 
implications, if any, for the 
safety of study participants and 
how will these be addressed? 
The PiCCO monitor as used in the protocol for 
minimally invasive cardiac output monitoring 
requires either a brachial or femoral arterial line as 
per the manufacturer’s guidelines. In addition, pre-
insertion scanning to ensure the artery is of 
adequate size (>3mm – in this case 3.7mm) is 
undertaken. We have now had two adverse events 
related to use of the system according to 
manufacturer`s guidelines. 
We propose action as follows:  
1. notification of MHRA (or equivalent national 
safety body) about the cluster  
2. notify the manufacturer again  
3. for this study we have been using PICCO to 
measure cardiac output as it is a well 
validated system for doing so – however at 
PHNT cardiac output is much more 
commonly measured, using an alternative 
system, the LiDCO Rapid. This is effectively 
a software application which re-analyses 
standard monitoring signals. It is within 
acceptable limits of comparison with gold 
standard measurement of cardiac output, 
though not as well validated as the PiCCO.  
 
5. Declaration 
 
Signature of Chief Investigator: Adam Kimble  
Print name: 
Adam Kimble 
Date of submission: 
07/01/2014 
 
 
  
 
204 
 
  
  
 
205 
 
 
 
 
  
 
206 
 
 
 
 
  
 
207 
 
 
 
 
  
 
208 
 
  
  
 
209 
APPENDIX 6 GEM manufacturer’s annual service and 
calibration, and monthly alcohol burn data 
GEM Nutrition Limited  Daresbury Innovation Centre 
  Keckwick Lane 
t. 01925 607000  Daresbury 
f. 01925 607398  Cheshire 
m. 07801 586208  WA4 4FS 
gem.nutrition@btinternet.com 
 
Registered in England no.:  4716714      Reg. office:  Daresbury Innovation Centre, Daresbury Cheshire 
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Adam Kimble 
Colorectal Research Fellow 
Derriford Hospital 
 
 
Service Report Plymouth GEM   Visit on: 28 August 
2013 
 
Reason for Visit:  Check overall GEM system is functioning after 
storage/move   Annual Service and Calibration 
   Operator training 
Observations: 
1. Initial Inspection all OK 
 
Comments –  Original Laptop not available so loaded software on XP 
Laptop 
 All works, except calibration progress windows not visible 
 
Corrective Action: 
1. N/A 
 
In addition: Replaced fan filter 
Replaced Nafion  
Calibration 
 
Alcohol Burn: 
Expected Actual Error % 
0.667 0.681 +2.1 
0.667 0.701 +5.1 
0.667 0.664 -0.45 
 
Flow Calibration:   
Expected Actual Error % 
0.0 0.0 0 
14.2 13.94 -1.8 
20.0 19.3 -3.5 
39.6 38.4 -3.0 
59.6 57.6 -3.4 
Max             74.0 71.7 -3.1 
 
Service and Calibration carried out by: 
Austen Bradley 
28 August 2013  
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Monthly alcohol burns: 
Date Actual Error % 
 
21/10/13 
 
0.661 -0.9 
0.659 -1.2 
0.687 +3.0 
 
06/01/14 
 
0.669 +0.3 
0.692 +3.7 
0.652 -2.2 
 
06/02/14 
0.651 -2.4 
0.678 +1.6 
0.665 -0.3 
 
06/03/14 
 
0.677 +1.5 
0.649 -2.7 
0.667 +0.0 
 
09/04/14 
 
0.662 -0.7 
0.673 +0.9 
0.673 +0.9 
 
12/05/14 
0.679 +1.8 
0.689 +3.3 
0.653 -2.1 
 
10/06/14 
0.651 -2.4 
0.684 +2.5 
0.696 +4.3 
 
28/11/14 
0.670 +0.4 
0.650 -2.5 
0.695 +4.2 
 
13/01/15 
0.674 +1.0 
0.642 -3.7 
0.688 +3.1 
 
10/02/15 
0.664 -0.4 
0.684 +2.5 
0.674 +1.0 
 
 
 
